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Abstract 
        The attitudes and experiences of the health care team members involved in facial transplant 
surgery and patient care were explored in this study, which utilized a qualitative descriptive method. 
The Specific Aims of the study and the interview questions were guided by “Moore’s Ethical 
Criteria for Surgical Innovation.” Overall, the participants believed that the risk-benefit ratio of 
facial transplantation favored proceeding with the procedure in the clinical scenarios with which 
they had been exposed. The participant’s experience was challenging and rewarding, and they 
expressed personal fulfillment from the opportunity to be involved in the transformation of another 
human being’s life. Moreover, the entire effort exhibited highly effective team work which displayed 
esprit de corps, was guided by superior leadership, and illuminated the importance of the clinical, 
intellectual, and historical environment of the institution where the procedures took place. These 
components represent a “surgical innovation cluster,” a proposed framework for guiding surgical 
innovative efforts which represent major paradigmatic shifts in both scientific effort and social 
philosophy. 
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Chapter 1 
State of the Science 
Introduction 
In the past seven years a total of 17 facial transplantation surgeries have been performed  
worldwide (Siemionow & Ozturk, 2012).  Facial transplantation is a surgical option when soft tissue 
and bone loss is accompanied by severe cosmetic, sensory, and functional deficiencies due to disease 
(Hui-Chou et al., 2010), trauma (Devauchelle et al., 2006; Ravindra, Wu, McKinney, Xu, & Ildstad, 
2009; Pomahac et al., 2011; Siemionow et al., 2009), or congenital malformations (Barker et al., 
2007). The procedure is an option only considered when all conventional reconstructive methods 
have failed (Barker et al., 2007; Morris et al., 2007).   
The introduction of facial tissue transplantation surgery engendered complex clinical, 
technological, and ethical patient care issues (Barker et al., 2007; Chenggang et al., 2008; 
Devauchelle et al., 2006; Morris et al., 2004; Morris et al., 2007). The complex issues included:  
determining patient selection criteria (Butler, Clarke, & Hettiaratchy, 2005; Pushpakumar et al., 
2010), refining donor tissue procurement techniques (Meninguad, Paraskevas, Ingallina, Bouhana, & 
Lantieri, 2008; Pushpakumar et al., 2010), predicting expected functional outcomes (Landin, 
Cavadas, Gonzalez, Rodriguez, & Caballero, 2008; Pushpakumar et al., 2010), appreciating the 
limitations of obtaining a fully informed consent for an innovative procedures (Hurlburt, 2007; King, 
2003; Reitsma & Moreno, 2006; Renshaw, Clarke, Diver, Ashcroft, & Butler, 2006), and 
deliberating the immunological response and post-operative immunosuppressant requirements of the 
recipient (Petit, Paraskevas, Minnus, Lee, & Lantieri, 2004; Pomahac, Aflaki, Chandraker, & Pribaz, 
2008; Swearingen et al. 2008; Wu, Xu, Ravindra, & Ildstad, 2009). Additionally, psychological 
implications for the patient (Clarke & Butler, 2009; Morris et al., 2007; Swindell, 2006), societal 
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consequences (Furr et al., 2006; Kalliainen, 2010), and ethical concerns (Hurlburt, 2007; O'Neill & 
Godden, 2009; Renshaw, Clarke, Diver, Ashcroft, & Butler, 2006) have been described.   
The U.S. Department of Defense (DoD) has acknowledged the emerging field of facial tissue 
transplantation as a research priority (Kowalczyk, 2009). United States military troops are equipped 
with better body armor today than during prior times of war (Johns Hopkins University Applied 
Physics Laboratory, 2009) and field triage and transportation mechanisms are also dramatically 
improved (Jenkins, 2011). Consequently, military men and woman are returning home with 
devastating, life-altering injuries that would have killed them in previous war times (Johns Hopkins 
University Applied Physics Laboratory, 2009). Among them are soldiers who have suffered partial 
or full facial deformities (Brigham and Women’s, 2011; Torriero, 2008). The DoD has awarded $3.4 
million to Brigham and Women's Hospital in Boston, Massachusetts, to advance face transplantation 
technology and patient care (Brigham and Women's Hospital, 2011). Brigham and Women’s staff 
performed the nation’s second face transplant in April, 2009, and have performed three additional 
facial transplantation procedures since that time. As we move forward to provide and understand this 
complex surgical procedure for patients, there are no data on the impact of this procedure on the 
interdisciplinary health care team members involved in the care of these patients. 
 The professional caregiver’s perception of involvement in solid organ procurement and 
transplantation procedures has been found to be morally complex and deeply important (Hibbert, 
1995; Regehr, Kjerulf, Popova, & Baker, 2004; Wang & Lin, 2009). The perception and experience 
of the health care team involved in facial transplantation procedures and patient care are unknown. 
Situations which highlight our mortality, present ethically-laden questions, and are innovative in 
nature, may have a long term personal and professional impact on caregivers (Jameton, 1993; 
Reitsma & Moreno, 2006). Consequently, the caregiver’s perception and experiences may directly or 
indirectly effect patient care (Jameton, 1984). There is no evidence to support the impact that caring 
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for patients involved in facial transplantation has on multidisciplinary healthcare team members. No 
studies have empirically described the experience of healthcare team members who have cared for 
this patient population.  
  Understanding the healthcare team member’s experience of involvement in facial 
transplantation will identify patient-related topics in need of further exploration, expand a narrow 
evidence-base, and suggest interventions to assure optimal patient outcomes. Describing their 
experiences will also help explain if personal or professional ethical challenges are a consequence of 
involvement in this innovative procedure.  
  Therefore, the purpose of this exploratory, qualitative descriptive study was to describe the    
 experience of the healthcare team members caring for patients receiving or donating a facial graft. 
This study was framed by Moore’s “Ethical Criteria for Surgical Innovation” (Moore, 1970, 1988, 
1989). 
The specific aims were: 
1. To describe the skill-set, attitudes, and experiences of the multidisciplinary healthcare team  
members who have been involved in facial transplant surgery and patient care. 
 
2. To describe the ethical impact on the multidisciplinary healthcare team members of 
involvement in facial transplant surgery and patient care. 
 
  The purpose of this chapter is to review the empirical literature on the emerging science of  
 
       facial transplantation; to define what is known on the topic, and to identify knowledge gaps which  
  
       support this study. 
 
        Historical Summary of Transplantation 
 
Solid Organ Transplant. Legendary  accounts of organ transplantation date back to 
348AD  when brothers Cosmos and Damian are said to have transplanted the leg of a recently 
deceased black Ethiopian man to a white man whose cancerous leg they had amputated (Barker et 
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al., 2007; Gander et al., 2006). In modern times, it wasn’t until the mid 1950s that the first 
reported successful kidney transplant was performed (Vasilic et al., 2008; Tilney, 2003). The 
field of transplant medicine advanced dramatically during the subsequent fifty years prevailing 
over clinical and technical challenges for caregivers, as well as moral and ethical issues for 
donors, recipients, and society as a whole (Tilney, 2003). Advances in knowledge about immune 
function and surgical techniques gave way to successful transplantation of other organs including 
livers, hearts, lungs, pancreases, abdominal organs, cornea, skin, and bone (Vasilic et al. 2008, 
Tilney, 2003). These organ and tissue transplants are now generally considered routine, life-
sustaining, surgical procedures (Vasilic et al. 2008). A persistent challenge to the expansion of 
transplantation efforts is the shortage of available organs for transplantation (US Dept. Health and 
Human Services, 2010). The gap between those needing organs and the availability of willing 
donors continues to widen (Roberts, 2003). 
 Composite Tissue Allotransplantation (CTA). The term “organ transplant” generally 
presumes the implantation of a kidney, heart, or other solid internal organ. Composite 
transplantation consists of the implantation of a combination tissue graft which may include bone, 
skin, muscle, tendon, and nerve (MD Anderson Cancer Center, 2011; Wu, Xu, Ravindra, & Ildstad , 
2009). Such transplant procedures have been undertaken to replace body parts lost to disease (Hui-
Chou, Nam, & Rodriguez, 2010), trauma (Devauchelle et al., 2006; Ravindra et al., 2009; Pomahac 
et al., 2011; Siemionow et al., 2010), or congenital malformations (Barker et al., 2007). Composite 
tissue transplantation procedures to date have included hand, abdominal wall, tongue, larynx, face 
(Morris et al., 2007; Swearingen et al., 2008; Wu et al., 2009), esophagus, and a vascularized knee 
(Wu et al., 2009). CTA is an option when multiple reconstructive surgical attempts have failed to 
resolve severe functional and aesthetic deficits (Barker et al. 2007; Morris et al., 2007). An estimated 
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7 million people per year in the United States could benefit from CTA (Barker et al. 2007; Gander et 
al., 2006; Wu et al. 2009).  
 Notably, the legendary account of the earliest organ transplant was the transplantation of a 
limb (Barker et al., 2007; Gander et al., 2006). Other early composite tissue transplantation efforts 
are described: the transplantation of a nose by Gaspare Tagliacozzi in the late 16
th
 century, and in the 
early 20
th
 century, the successful transplant of a hind leg of a dog by Alexis Carrel and the 
heterotopic allotransplantation of the heads of dogs by Guthrie (Barker et al. 2007). However, the 
immunological barriers to successful organ transplantation were as yet unconquered (Barker et al. 
2007).  
 Other milestones and outcomes in the development of CTA are reported (Appendix A).  In 
summary, a total of approximately 62 hand transplantation procedures in 46 patients have been 
performed throughout the world (Jewish Hospital & St. Mary’s Healthcare, Kleinert Institute, 
Kleinert Kutz Hand Care Center, and University Of Louisville School Of Medicine, 2011). The 
success of hand transplantation surgery supported the advent of facial transplantation efforts as many 
technical, clinical, and ethical challenges are shared (Barker et al., 2007). A total of 17 facial 
transplantation procedures (Appendix B) have been performed worldwide since 2005 (Siemionow & 
Ozturk, 2012). 
Emerging Science of Facial Transplantation 
  The complexity of the human face’s functional and aesthetic properties, and the prospect of 
reassigning such complexities from one human being to another, has “captured the interest and 
imagination of the media, scientists, physicians, and the lay public” (Barker et. al., 2007, p. 233). 
The role of the face in the expression of emotion, and as the gateway to an individual’s social 
interactions (Barker et al. 2007), gives the prospect of this type of transplant a very different gestalt 
than the solid organ transplantation of a heart, lung, or kidney (Prior & Klein, 2011). 
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 Early deliberations regarding the appropriateness and feasibility of facial transplantation 
surgery generated significant discussion (Barker et al., 2007; Morris et al., 2004; Powell, 2006). A 
multiplicity of factors regarding facial transplantation surgery and its subsequent treatment were 
illuminated by these discussions (Alexander, Alam, Gullane, Lengele', & Adamson, 2010; Morris et 
al., 2004; O'Neill & Godden, 2009; Powell, 2006; Wiggins et al., 2004). Factors included those 
inherent to innovative surgical procedures: the surgeon’s autonomy and capacity for therapeutic 
decision making, the lack of capacity to obtain a fully informed consent, and the uncertain nature of 
a risk-benefit ratio analysis (Kalliainen, 2010; King, 2003; Paradis et al., 2010; Reitsma & Moreno, 
2006).  Additionally, factors common to the broader science of transplantation were included: the 
development of donation protocols and the prioritization for organ distribution (Blogowski, 2009; 
Kalliainen, 2010), and subjecting recipients to life-long immunosuppressive therapies post-transplant 
(Bermudez, 2006; Blogowski, 2009; Kalliainen, 2010; Petit et al., 2004). Importantly, factors unique 
to facial transplantation surgery were also discussed: the potential for significant psychological 
consequences for the recipient (Clarke & Butler, 2009; Morris et al., 2007; Swindell, 2006),  
including questions regarding personal identity and subjectivity (Clarke and Butler, 2009; Fitchett, 
2008; Morris et al. 2007, Swindell, 2006), societal consequences (Furr et al., 2006; Kalliainen, 
2010), and ethical concerns (Hurlburt, 2007; O'Neill & Godden, 2009; Renshaw et al., 2006) 
 To follow is a synthesis of the literature as background for the emerging science of facial 
transplantation. The review is divided into three sections: clinical considerations, psycho-social 
consequences, and ethical issues. 
 Clinical Considerations. Seventeen facial transplantation procedures have been performed 
worldwide since 2005 (Siemionow & Ozturk, 2012). Two of the seventeen patients have died. The 
patient who underwent the second-ever face transplant procedure in China in April 2006, died 
twenty-seven months after transplant (Hui-Chou et al., 2010). The patient who received the first 
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simultaneous face-bilateral hand transplant in France in April 2009, died two months after transplant 
of septic shock (Siemionow, Zor, & Gordon, 2010). Despite these deaths, the procedure has been 
lauded as a practical and feasible option for those with devastating disfigurements (Devauchelle et 
al., 2006; Pomahac, 2011; Siemionow, Zor, & Gordon., 2010). Several of the transplant patients 
have regained function, as well as sensory and motor capabilities, while reportedly adjusting well 
psychologically to their new “organ” (Devauchelle et al., 2006; Pomahac et al., 2011;  Siemionow, 
Papay, Djohan, Bernard, Gordon, Alam…Fung, 2010).    
      Immunology. Immunological response is inevitable following the transplantation of tissue 
(Tilney, 2003). In 1954, Dr. Joseph Murray led a team of surgeons in the first successful solid organ 
transplant, a kidney (Barker et al., 2007; Morris et al., 2007; Tilney, 2003).  The donor and recipient 
patients were identical twins mitigating the risk of a devastating immunological response (Barker et 
al., 2007; Morris et al., 2007).  This hallmark surgical procedure is regarded as one of the greatest 
breakthroughs of modern medicine (Barker et al. 2007).  However, the advancement of organ 
transplantation science has only been realized due to advances in immunosuppressive therapy and 
tissue typing processes (Gander et al., 2006; Pomahac et al., 2008; Morris et al., 2007; Barker et al., 
2007). Kidney, liver, heart, pancreas, intestine, lung and heart-lung organ transplantation procedures 
are now considered routine (Department of Health and Human Services, 2010).    
 The tragedies of war time have often coincided with revolutions in medical science and the 
field of immunology is no exception (Gander et al., 2006).  Following the Battle of Britain during 
World War II, significant progress was made understanding the immune response when severely 
disfigured fighter pilots received skin grafts (Gander et al. 2006).  Discoveries made during this time 
period provide the framework for the field of transplant immunology (Gander et al. 2006).  Skin is 
recognized for its immunogenic properties, and because it is a major component in facial 
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transplantation, many early discussions reported trepidation about anticipated issues of acute and 
chronic rejection (Barker et al., 2007; Morris et al., 2007; Swearingen et al., 2008; Wu et al., 2009).   
 The patient receiving a facial transplantation will require a life-long immunosuppressive 
medication regimen (Morris et al., 2004; Morris et al., 2007; Swearingen et al., 2008; Wu et al., 
2009). Side effects and the propensity to create conditions that may shorten the life span are well-
established consequences of this class of medications (Morris et al., 2004; Morris et al., 2007; 
O'Neill & Godden, 2009; Powell, 2006; Swearingen et al., 2008; Wu et al., 2009).  In life-saving 
situations, the risk-benefit ratio is considered acceptable, however subjecting patients to these risks 
following reconstructive surgical procedures has been controversial (Morris et al., 2004). 
Additionally, patient selection criteria must include a comprehensive evaluation of the potential for 
the patient to remain adherent to the required life-long therapies (Chenggang et al., 2008; Pomahac, 
et al., 2008; Pushpakumar et al., 2010).  Postoperatively, facial transplant recipients have 
experienced varying levels of rejection (Devauchelle et al., 2006; Morris et al., 2007; Pomahac et 
al., 2011; Siemionow et al., 2009). However, all are reported to have successfully responded to 
increased or altered immunosuppressive therapies (Devauchelle et al., 2006; Morris et al., 2007; 
Pomahac, 2011; Siemionow et al., 2009).  No episode of rejection had resulted in graft loss, though 
the cause of death of the second face transplant patient has been reported to follow an episode of 
acute rejection after the patient ceased immunosuppressive therapy and initiated herbal therapy at the 
suggestion of witch doctors in his remote village (Chenggang et al., 2008).  The speculation that 
controlling rejection following facial transplantation would require high-intensity 
immunosuppressive therapy has been unsubstantiated, and recipients have been maintained on 
dosages similar to patients post renal transplant (Gander et al., 2006; Swearingen et al., 2008).  
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Extensive work continues in the area of immunology and specifically, the potential for inducing 
donor-specific tolerance (Swearingen et al., 2008).  
         Technical Processes. The technical procedures and sophisticated micro-vascular techniques 
used during facial transplantation procedures are similar to those used in other complex 
reconstructive surgical procedures (Pushpakumar et al., 2010). Facial transplantation procedures are 
undertaken after conventional methods of reconstruction have been attempted and failed (Barker et 
al., 2007; Gander, 2006; Morris, 2007; Swearington, 2008).  All currently transplanted patients had 
previously undergone multiple surgical procedures and revisions prior to face transplant, which was 
considered an extreme and unusual intervention (Devauchelle et al., 2006; Siemionow et al., 2009, 
Pomahac, 2011). Some case reports describe surgical results, including both aesthetic and functional 
outcomes which are superior to conventional reconstructive treatments (Pomahac, 2011).  
 Psychosocial Consequences. The psychosocial consequences of facial transplantation 
surgery are multifactorial (Barker et al., 2008; Clarke & Butler, 2009; Fitchett, 2008; Furr et al., 
2007; Hui-Chou et al., 2010; Kalliainen, 2010; Morris et al., 2007; Swindell, 2006). Among these 
factors are: understanding the “role of face” in social interactions (Morris et al. 2007), interpreting 
how facial expression affects an individual’s personal identity and societal roles (Fitchett, 2008; Furr 
et al. 2007), quantifying the impact of an individual’s facial disfigurement on their self-esteem 
(Morris et al. 2007), evaluating a patient’s expectations regarding the outcome of facial transplant 
surgery (Barker et al. 2008), and assessing the availability of appropriate social supports for the 
transplant recipient post-operatively (Hui-Chou et al. 2010; Morris et al. 2007). The potential for 
facial transplantation surgery to alleviate long-term psychosocial difficulties for disfigured 
individuals remains unknown due to the novel nature of the procedure (Furr et al. 2007). Case 
reports of early transplants have reported positive results regarding renewed social interaction 
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without psychological disturbance (Pomahac, 2011; Siemionow, Papay, Djohan, Bernard, Gordon, 
Alam…Fung, 2010).   
 Clark and Butler (2009) describe the following criteria for consideration to ensure appropriate 
patient selection for the procedure:  “…issues of altered appearance and identity, adjustment to 
change, the management of suboptimal adherence to immunosuppression,…and how we present and 
understand risk, particularly related to immunosuppression and rejection” (p.  1087).  
  The donor family must also be considered as the psychosocial ramifications of donating a 
loved one’s face may be complex (Fitchett, 2008). Issues of identity, and the thought that a loved 
one “lives on” may foster complications for the grieving family during, and subsequent to, the 
decision to participate in facial tissue donation (Fitchett, 2008). The results of the transplant 
however do not represent a physical replication of the donor as the transplanted tissue takes on the 
facial structural support of the recipient. Nor does the recipient again look like his/her original self 
(Fitchett, 2008).   
 The final category of potential psychosocial consequences is the impact of facial transplant 
surgery on multi-disciplinary healthcare team members. There are few empirical studies published 
on this topic. However, the existing studies involve the attitudes and opinion of professional 
caregivers during the conceptual phase of facial transplantation efforts (Clarke et al., 2007; Mathes, 
Kumar, & Ploplys, 2009; Vasilic et al., 2008) and will be reviewed in the section of this chapter 
“Healthcare Team Members and Facial Transplantation.” The psychosocial consequences of 
caregivers who have been involved in facial transplantation procedures and patient care has not been 
explored. 
      Ethical Impact of Facial Transplantation. The novel and innovative nature of facial 
transplantation surgery has captured the attention and imagination of health care providers, patients, 
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and society as a whole (Belanger, Harris, Nikolis, and Danino, 2009). The ethical questions 
regarding the procedure and subsequent treatment were widely discussed and central to early debates 
on the feasibility of this innovative surgery (Barker et al., 2007). Ethical arguments as to the 
appropriateness of the procedure are abundant; both in favor (Alexander et al., 2010; Kalliainen, 
2010; Morris et al. 2007) and against (Kalliainen, 2010; Morris et al., 2004; Strong, 2010).  
          The most frequently discussed ethical question is that of subjecting individuals to required life-
long immunosuppressive therapy following transplantation (O’Neil, 2009; Powell, 2006; Renshaw et 
al., 2006; Wu et al., 2009).  An increased risk of developing diabetes, infection, cancers, and renal 
toxicity exist with this therapy (O’Neil, 2009; Powell, 2006; Renshaw et al., 2006). Critics argue 
facial transplant surgery is not “life-saving” in the same manner as heart, lung or kidney transplants, 
and therefore the risks of immunosuppressive therapy may outweigh the benefits of the procedure 
(Morris et al., 2004; Strong, 2010). Proponents argue that restoring functional capabilities is life-
restoring and dramatically improves the patient’s quality of life (Alexander et al., 2010; Clarke & 
Butler, 2009; Pomahac et al., 2011). Should the patient develop a resistant infection or becomes non-
adherent to immunosuppressive therapy which results in graft rejection, graft loss may result 
(Strong, 2010; Wu et al., 2009). Few options remain for the patient should this occur (Strong, 2010). 
         Additionally, the ability to obtain a fully informed consent assuring patient autonomy is 
difficult with innovative procedures (Reitsma & Moreno, 2006). However, Institutional Review 
Board approval has been obtained prior to undertaking the procedure (Siemionow & Gordon, 
2010b). As this procedure is still considered experimental, the financial burden for such procedures 
is absorbed by the health care system (Kalliainen, 2010). If the patient fails to comply with 
necessary treatment to preserve their transplant, the health care system must support them through 
subsequent surgical interventions and treatment, presumably at great financial cost (Kalliainen, 
2010).  
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 Publications speculate on future trends and ask what implications the facial transplantation has 
for future cosmetic procedures (Belanger et al., 2009; O’Neill and Godden, 2009; Powell, 2006). 
Though it seems unlikely that the procedure would ever become routine as a means of changing 
one’s identity, media representations and film productions have suggested this may be the case. The 
argument about the level of disfigurement that may be acceptable in the future as indication for the 
surgery is also prevalent (Chenggang et al., 2008; O’Neill and Godden, 2009).  
 The decision to subject a patient to  lifelong immunosuppressive therapy as well as to a variety 
of other medical complications that this type of surgical procedure may generate, may potentially 
create ethical questions for the healthcare team members (Clarke et al., 2007). Equally concerning is 
the experience of the healthcare team members caring for the donor patient. Studies addressing the 
attitudes and opinions of healthcare team members toward facial transplant surgery and these ethical 
questions have been conducted (Clarke, Simmons, White, Withey, & Butler, 2006; Clarke et al., 
2007; Mathes et al., 2009; Prior & Klein, 2011; Vasilic et al., 2008). However, all were done during 
the conceptual phase of facial transplantation surgery and therefore based on speculation, rather than 
experience. No published research studies have yet explored the personal experiences or ethical 
considerations of caregivers who have actually cared for this patient population.  
Conclusion. The complex clinical, technical, and immunological patient care issues in this emerging 
science appear to mirror those of other reconstructive and organ transplantation procedures 
(Devauchelle et al., 2006; Siemionow et al., 2009). The short-term results have been positive 
however the long-term physical, emotional, and psychological effects on the recipient patient, as 
well as long-term consequences to the donor’s family are yet to be validated (Siemionow & Gordon, 
2010a). Ethical arguments as to the appropriateness of the procedure were abundant during the 
conceptual phase of the procedure. The ethical impact on the healthcare team members involved in 
this innovative procedure is unexplored. 
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Healthcare Team Members and Organ Transplantation 
 Team Members and Skill Sets. The desire to treat end-stage renal disease with kidney 
transplantation became a reality in the 1950’s (Moore, 1995; Tilney, 2003). Francis Moore lauded 
the team approach to early efforts describing the necessity of a Department of Surgery willing to 
undertake the innovative procedure, supported by a Department of Medicine with expertise in 
kidney disease, and strengthened by a clinically powerful Pathology department interested in the 
microscopic appearances of transplanted organs (1995). Importantly, the progression of  kidney 
transplantation in the 1950s evolving into acceptance of solid organ transplantation as routine, life-
sustaining surgery (Vasilic et al., 2008) was a direct result of continued advances in immunology 
(Butler, Roderick, Mullee, Mason, & Peveler, 2004; Linden, 2008; Tilney, 2003) and the 
management of infectious diseases (Linden, 2008).   
 The early reports of multidisciplinary transplantation efforts describe various specialty trained 
physicians as critical team members (Linden, 2008; Murray, 2001; Moore, 1995). However, the 
transplant teams described today, in addition to the surgeons, nephrologist, pathologists, and 
immunologist, include  anesthesiologists, nurses, transplant coordinators, social workers, 
psychologist and psychiatrists, dietitians, financial coordinators, chaplains and occupational and 
physical therapists (American Association of Kidney Patients, 2011). Additionally, pharmacists, 
organ procurement specialists, donor advocates, and multiple ancillary staff members are important 
components of the multidisciplinary transplantation teams. As the need to assemble multi-
disciplinary teams for face transplantation patient care is new, defining team composition and 
describing the necessary skill-sets required will provide guidance for future efforts.   
 Team Members’ Attitudes and Experiences. Although extensive empiric data are available 
regarding the technical and immunological aspects of tissue transplantation, the family member’s  
decision to donate (Manuel, Solberg, & Macdonald, 2010; Moraes et al., 2009; Van Leiden, Jansen, 
& Haase-Kromwijk, 2010), and the experiences of recipient patients and their quality of life 
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measurement related to transplantation (Devine, Reed-Knight, Simons, Mee, & Blount, 2010; 
Parikh, Ladner, Abecassis, and Butt, 2010; Rodrigue et al., 2010), little is known about the direct 
experiences of multidisciplinary team members. Among the health-care providers issues that have 
been explored are: the attitude of the health care team members regarding organ donation 
(Rodriguez-Villar et al., 2009), the role their attitudes  play in promoting transplantation efforts 
(Fonouni et al., 2010; Siminoff, Arnold, & Caplan, 1995), and the experience of nurses working with 
potential organ donor patients in intensive care units (Hibbert, 1995; Kim et al., 2006) and during the 
organ procurement process (Page, 1996; Regehr et al., 2004; Saviozzi, 2010; Wang and Lin, 2009; 
Smith, Leslie, & Wynaden, 2010). 
         Attitudes. Members of the healthcare team are on the front line of providing information 
and education on health-related topics to patients, families and the general public. This is also the 
case with organ transplantation. The significant issue of the shortage of available organs for 
transplantation continues to challenge the medical community. More than 105,000 individuals are 
awaiting organ transplantation (US Dept. Health and Human Services, 2010) and the gap between 
those needing organs and the availability of willing donors continues to widen (Roberts, 2003). 
Therefore, the attitudes and experiences of the team toward organ donation are critical and may 
impact requests for donation and overall availability of organs for transplantation (Rodriguez-Villar 
et al., 2009). Thus far, little is known about those team members who have had direct contact with 
patients that have received face transplants. 
       Siminoff, Arnold, & Caplan (1995) studied health care providers (N= 568) attitudes about organ 
donation and reported a positive attitude about organ donation was found to correlate with being 
more likely to request donation (r=.62; p=.000).  Fonouni et al., (2010) found that instituting an 
interdisciplinary transplant team with a common goal of increasing living kidney donation resulted 
in a 48% increase in donation.  
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        Experiences. The experiences of nurses working with potential organ donor patients in 
intensive care units (Hibbert, 1995) and caring for the patient during the organ procurement process 
(Page, 1996; Regehr, Kjerulf, Popova, & Baker, 2004; Saviozzi, 2010; Wang and Lin, 2009; Smith, 
Leslie, & Wynaden, 2010) have been described. The actual experiences of other health care 
providers are less well explored.  
 Hibbert (1995) conducted a retrospective, exploratory, descriptive study of nurses (N= 17) 
working in a neurological intensive care unit. The study was guided by Lazarus and Folkman’s 
Stress and Coping Theory (Hibbert, 1995). Individual interviews were conducted to explore the 
nurses’ appraisal of stressors experienced while caring for organ donors and their families (Hibbert, 
1995). Stressors identified by the participants included: the threat of losing a patient, inconsistency 
of some physicians in intervening in the process, some family’s difficulties understanding brain 
death, and the need for more time and knowledge to address family needs (Hibbert, 1995). Requests 
for education on the issue of grief, crisis interventions, stress, coping theories were elicited from the 
participants (Hibbert, 1995). Additionally, the study participants desired an opportunity to discuss 
their feelings and experiences during debriefing sessions following caring for this patient population 
(Hibbert, 1995). 
 The experiences of perioperative nurses participating in organ procurement procedures have 
been reported (Carter-Gentry & McCurren, 2004; Page, 1996; Regehr et al., 2004; Wang and Lin, 
2009). Nurses participating in these procedures found the process highly stressful. Page reported that 
perioperative nurses described the process of organ procurement surgery as “an emotive procedure, 
fraught with ethical and moral dilemmas” (p. 9).   
        Carter-Gentry & McCurren’s (2004) qualitative study consisted of semi-structured interviews 
with perioperative nurses (N=8) and sought to explore challenges faced when participating in the 
procurement process. The challenges identified were:  acknowledging the abrupt cessation of life, 
sympathy for the family members, personalization of events, post-mortem care, and a shift in 
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thinking from usually saving a life with a surgical intervention, to ending one (Carter-Gentry & 
McCurren, 2004). 
        Regehr et al. (2004) conducted in-depth qualitative interviews with operating room nurses who 
participated in organ procurement procedures (N=14) working in a large urban trauma center. The 
study concluded that the procedure resulted in distress among the nurses. The stressors identified 
include: difficult relationships among the surgical teams, concern for the dignity of the patient, the 
well-being of the family, and exposure to death and trauma (Regehr, 2004).     
       The experiences, feelings, and self-care strategies of Taiwanese perioperative nurses (N=6) 
during the organ procurement process was qualitatively studied by Wang & Lin (2009). Results of 
the face-to-face interviews concluded that witnessing death make the nurses “uncomfortable and 
even induced trauma” (p. 278). Self-care measures undertaken by the participants included time for 
reflection engaging in leisure activities, embracing religious beliefs, separating work and leisure 
time, exercise and sharing (Wang & Lin, 2009).                                                                                                                                                                                                                                                                                                               
 Summary. Studies have demonstrated the impact of the attitudes of the multidisciplinary 
health care team members on the availability of organs for transplantation. Additionally, the 
experience of nurses in intensive care units and operating rooms during the organ donation process 
has been found to be exceedingly difficult. Therefore, it is important to understand the impact of the 
health care team’s experience with facial transplant patient care. Not only might the experiences 
impact patient outcomes, but may affect the individual care giver’s personal and professional well-
being as well.  
Healthcare Team Members and Facial Transplantation 
  The advent of facial transplantation surgery has challenged the healthcare team to provide 
physical care to a patient population using knowledge gained from caring for others who have 
undergone other similarly complex reconstructive and transplantation surgical procedures. The 
availability of technically advanced, often experimental and innovative procedures present options to 
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patients not previously thought possible. Acute patient care issues as well as long-term patient 
outcomes to newly introduced techniques and procedures are often speculative, and the impact of 
involvement on the healthcare team members unknown. Such is the case with facial transplantation 
surgery. 
           Team Members and Skill Set. Post-procedure case details by individual surgical teams who 
have performed facial transplantation procedures have been reported (Devauchelle et al., 2006; Hui-
Chou et al., 2010; Pomahac et al., 2011; Siemionow et al., 2010) and recommendations for others 
planning to undertake the procedure in the future have been outlined (Siemionow & Gordon, 2010a). 
The recommendations include strategies to promote Institutional Review Board acceptance of the 
procedure as a research-based initiative (Pomahac et al., 2008; Siemionow & Gordon, 2010b), 
simulated surgical procedures to refine the surgical plan (Pomahac et al., 2008; Siemionow & 
Gordon, 2010a), and determination of patient selection criteria (Pomahac et al. 2008; Siemionow & 
Gordon, 2010a). Additionally, members of the multidisciplinary team involved in the screening and 
management of patients planning to undergo facial transplantation surgery have been categorically 
outlined by one transplant center (Siemionow & Gordon, 2010a), and captures the vastness of this 
patient care effort.  
  There are multiple unique and well-developed skill-sets required to care for this complex 
patient population and this is directly addressed by Specific Aim #1 of this study.  It is 
recommended that this procedure be undertaken only at university-based institutions due to the 
availability of diverse resources (Siemionow & Gordon, 2010a). Multidisciplinary team members 
identified by one institution performing the procedure include: a Plastic Surgery team leader 
supported by physicians with specialization in cranio-maxillo-facial surgery, micro-surgery, 
transplant surgery, ear, nose and thoat/head and neck surgery, ophthalmology, anesthesiology, 
infectious diseases, psychiatry, and dentistry (Siemionow & Gordon, 2010a). Additionally, a 
psychologist, social worker, face transplant coordinator, physical and speech therapists, bioethics 
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representative, and media spokesperson are key team members (Siemionow & Gordon, 2010a). 
Other health care team members involved in facial transplantation patient care include nurses across 
the continuum of care, nursing assistants, security officers, organ procurement organization 
professionals, occupational therapist, chaplaincy staff, Family & Patient Relations staff members 
and multiple ancillary personnel. There are no published studies which describe the personal, 
professional, and ethical experiences of the healthcare team members who have participated in facial 
transplant procedures. Considering the tremendous diversity of professionals and associated 
personnel, a comprehensive description of their experiences is warranted.  
           Team Members’ Attitudes and Experiences. Thus far, only a few empirical studies have 
been published on the topic of facial transplantation. However, four studies examined the attitudes 
and opinion of professional caregivers and/or the general public with regards to the innovative 
procedure (Clarke et al., 2007; Mathes et al., 2009; Prior & Klein, 2011; Vasilic et al., 2008).  
Notably, each study was carried out prior to the first facial transplantation procedure. Therefore, the 
data were not based on direct experiences of the participants caring for facial transplantation 
patients. However, this small body of literature can provide some insight into team members 
attitudes and experiences. 
  Attitudes. The earliest study (Vasilic et al., 2008) explored the amount of risk that would be 
tolerated by individuals when considering whether to proceed with facial transplant surgery using a 
quantitative, survey-based design. Vasilic sampled five groups of individuals (N= 305): facially 
disfigured (n=33), reconstructive surgeons (n= 45), recipients of other organ transplants (n=42), 
professionals who manage immunosuppressive therapy for transplant recipients (n=37), and a 
healthy control group (n=148) using the Louisville Instrument for Transplantation survey tool 
(Cronbach’s α = .748 for facial tissue transplant). The instrument was developed to objectively 
measure transplantation risk acceptance (Vasilic et al., 2008). Risk was operationally defined in 
terms of time trade-off, benefits versus risks of long-term immunosuppressant therapy, and through a 
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standard gamble estimate of success versus failure rates (Vasilic et al., 2008). The study found that 
the five groups significantly differed from each other in the amount of risk they would accept (F4, 299 
= 6.52, p<0.0001) to receive either a kidney or a face transplant (Vasilic et al., 2008). Additionally, 
it was found that all groups would accept greater risk to receive a face transplant than a kidney 
transplant (F1, 299= 4.47, p= .035) (Vasilic et al., 2008). The study concluded that the healthy 
volunteer control group would accept the most risk, while the reconstructive surgeons would accept 
the least (Vasilic et al., 2008). The differences found in this study may suggest that individuals with 
different experiential bases evaluate the risks of facial transplantation differently (Prior & Klein, 
2011). 
   Clarke et al., (2007) conducted a mixed methods study to evaluate transplant professionals’ 
attitudes toward facial transplantation in the United Kingdom.  A questionnaire generated from a 
focus group of transplant coordinators was utilized (Clarke et al., 2007). Three main themes were 
generated by the focus group and were reflected in the questionnaire: organ retrieval issues, issues 
affecting the team, and issues related to the donor family (Clarke et al., 2007).  The sample (N=170) 
consisted of 80% nurses including operating room staff, and 18% transplant coordinators (Clarke et 
al., 2007). The sample was not further defined. The questionnaire was administered following a 
lecture given by a surgeon leading the development of a facial transplant program in the United 
Kingdom (Clarke et al., 2007). The study found that 76% of participants supported facial 
transplantation procedures, while 23% felt more research was needed prior to its initiation (Clarke et 
al., 2007). Importantly, no participants disagreed in principle with the procedure (Clarke et al., 
2007). There was a significant association (x
2
2=8.28, p =.016) between knowing someone with a 
disfiguring condition and being in favor of facial transplantation (Clarke et al., 2007).  In addition, 
participants recommended that more attention be paid to the “needs of the donor family, support for 
the team, and the development of clear management pathways” (Clarke et al., 2007, p.  232). The 
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recommendation of “support for the team” (Clarke et al., 2007, p. 232) is noteworthy in support of 
the current study. 
  Mathes, Kumar, and Ploplys (2008) utilized a web-based survey to assess presumed risk to 
benefit ratio and the evaluation of clinical indications for facial transplant in three patient scenarios. 
As such, the participants utilized personal, professional and ethical judgment.  The sample (N=164) 
consisted of burn and plastic surgeons. The strongest support for the procedure was found with the 
scenarios detailing multiple failed reconstructions and when the patient had sustained total facial 
burns. Respondents also supported the advancement of immunosuppressive protocols (Mathes et al., 
2008).       
  A qualitative study (Prior & Klein, 2011) assessed the attitudes of a small sample of the 
general public (n= 8) and medical professionals (n=8) toward face transplantation. The medical 
professionals group consisted of 4 males and 4 females; 4 (2 male, 2 female) who were nurses and 4 
(2 male, 2 female) who were physicians. In-depth, semi-structured interviews were carried out to 
assess the level of support for the proposed procedure (Prior & Klein, 2011). Five themes emerged: 
agreement in principle, caveats and conditions, medical and technical difficulties, function and 
appearance, and the significance of the human face (Prior & Klein, 2011). The technical feasibility 
of the procedure, the quality of life for the recipient and the ability to cope with the changed 
appearance were concerns for both the general public and the medical professional groups (Prior & 
Klein, 2011). 
         Prior & Klein (2011) identified a difference in attitudes and beliefs between the general public 
and medical professional groups in the following areas: the quality of the recipient’s appearance, the 
possibility and likelihood of ethical abuse, and the medical and technical difficulties of the 
procedure. Specific variances between groups were not reported except for one (Prior & Klein, 
2011). The medical professional group had greater concern for possible consequences of long-term 
immunosuppressant therapy, and for the possibility of graft failure. A limitation of the study, as 
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identified by the authors was that the participants had no first-hand knowledge of facial 
transplantation (Prior & Klein, 2011). Additionally, a recommendation was made to repeat the study 
with a more homogenous sample (Prior & Klein, 2011). This limitation and recommendation will be 
addressed by the current study. 
           Experiences. Neither the personal or professional experiences, nor the ethical impact on the 
health care team involved in facial transplant patient care, have been explored. Describing the 
experiences of the health care team and exploring the ethical impact will be addressed in this study 
through Specific Aim #2. 
           Summary. The studies by Vasilic et. al. (2008), Clarke et al. (2007), Mathes et al. (2008) 
quantitatively examined the attitudes and opinions of multidisciplinary professionals during the 
conceptual phase of facial transplantation. Prior & Klein (2011) qualitatively examined the attitudes 
of medical professionals and the general public toward facial transplantation. Significantly, none of 
the existing empirical literature examines the multidisciplinary health care team member’s attitude, 
experience, or the ethical impact after caring for a patient undergoing facial transplantation. This 
study qualitatively examined the experience of professionals who have been directly involved in 
facial transplantation patient care.   
State of the Science Summary 
 The majority of published evidence is from publications prior to the successful undertaking of 
facial transplantation procedures, and is therefore speculative in nature.  Since that time, it has been 
reported that the immunological, clinical, and technical barriers to facial transplantation do not 
appear insurmountable (Devauchelle et al., 2006; Pomahac et al., 2011, Siemionow et al., 2009).  
Moral and ethical issues in circumstances of severe and debilitating disfigurement with 
accompanying functional deficits, are reported (O’Neill and Godden, 2009; Siemionow et al., 2009). 
The long-range implications of this novel procedure, its impact on the donor family and recipient, 
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are unknown. The experience of the healthcare team and its impact on the future of facial transplant 
efforts is also unknown.  
  Innovative patient care options such as facial tissue transplantation have received significant 
focus and imaginative critique in the media. Little is known about the professional and personal 
impact on the health care team members that involvement in these life-altering, innovative 
procedures might have. Providers of health care services who confront this type of innovative 
procedure in their work may interpret it as laden with ethical complexities as the procedure itself, 
and subsequent treatment, so profoundly relate to issues of quality of life, utilization of resources, 
and issues of personal identity. The uncertainty regarding patient outcomes following 
technologically advanced interventions has been associated with an intensification of ethical and 
moral dilemmas for caregivers in acute care settings (Schluter, Winch, Holzhauser & Henderson, 
2008). Therefore, it is imperative that the impact of involvement in facial transplant surgery has on 
healthcare team members be explored.  
 
 
 
 
 
 
 
 
 
 
 
23 
 
Chapter 2 
Conceptual Framework 
 
Introduction 
 Ethical questions are intrinsic to therapeutic innovation (Moore, 1965, 1970, 1988, 2000). 
This concept is extensively supported in the literature (Chong, 2007; Dean, 2001; King, 2003; Palma 
& Rosenbaum, 2009; Reitsma & Moreno, 2006). Consequently, the degree of acceptability of a 
therapeutic innovation may result in both scientific discourse and in ethical discourse (Moore, 1965, 
1970, 1988, 2000).  
Moore’s “Ethical Criteria for Surgical Innovation” (1970, 1988, 1989, 2000) provides a 
contextual framework to contemplate when determining the acceptability of a new procedure or 
technique.  Moore’s framework for ethical acceptability of an innovation encourages scientific 
integrity through the mandate of compulsory laboratory work and the evaluation of the statistical 
likelihood of a positive outcome (Moore, 1970, 1988, 1989, 2000). This conviction will be further 
discussed in a subsequent section of this chapter. Additionally, it provides a conceptual framework 
to explore ethical perspectives of medical innovation with the providers involved in the procedure. 
Thus, it was used to undergird the present qualitative descriptive study, and to guide the initial 
interview questions. It was appropriate to use an ‘innovation and ethics framework’ given the 
discovery nature of the present study. Moreover, a framework developed by the physician who was 
an instrumental leader at the institution that performed the first successful kidney transplant, an 
institution that has now performed four facial transplant procedures, provided historical significance. 
 Dr. Francis Moore became surgeon in chief at the Peter Bent Brigham Hospital and the 
distinguished Moseley Professor of Surgery at Harvard Medical School at the age of thirty-four 
(Moore, 1995; Time, 1963). He is well known for defining the metabolic care of the surgical patient, 
pioneering tumor and abscess localization using radioactive isotopes, the inaugural work with heart 
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valve replacement surgery, and the advent of organ transplantation surgery (Chong, 2007; Moore, 
1995; Tilney, 2003). During his tenure as Surgeon-in-Chief at Brigham and Women’s Hospital, the 
staff at the institution performed the first successful kidney transplant between identical twins 
(Tilney, 2003). Importantly, this success followed twenty-five failed attempts; most patients dying 
within weeks and the longest living 5 months (Gawande, 2003). It is unclear whether these failed 
attempts altered Dr. Moore’s beliefs about the ethics of therapeutic innovation (Francis D. Moore Jr., 
personal communication, July 15, 2010) though it has been reported so (Gawande, 2003). 
Subsequently, Dr. Moore wrote extensively about the ethical problems unique to surgery 
(Moore, 2000), the “ethical revolutions” brought about by the science of transplantation (Moore, 
1988), and the ethical boundaries of therapeutic innovation (Moore, 1970). It is the latter two areas 
of his work which provide support for this study. Moreover, it is his suggested criteria for evaluation 
of the ethical boundaries of a therapeutic innovation, which provide the framework. 
Ethical Revolutions and the Science of Transplantation 
Dr. Moore outlined three basic ethical assumptions challenged by the science of 
transplantation: “primum non nocere, the ethics of therapeutic innovation and desperate remedies, 
and the limits of voluntarism” (Moore, 1988). Specifically, Moore scrutinized ethical difficulties 
within the science of transplantation, including the drug-induced immunological suppression 
required to assure transplantation success; reminding us that this is based in an unnatural 
physiological response (Moore, 1970). Furthermore, the use of organs from another brings ethical 
questions concerning harming one human to help another in the case of living donation, and 
questions related to the declaration and definition of death in the case of cadaveric donation (Moore, 
1988). Importantly, these arguments were not meant to forego transplantation efforts, but rather as 
an illumination of the difficult ethical concerns produced with the development of transplantation 
(Moore, 1970, 1988).                                                                                   
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Ethical Boundaries and Therapeutic Innovation 
         In order to promote ethical boundaries for innovative surgical procedures and techniques, 
Moore believed that "good science [was] ethical science" (Moore, 1965, P. 359). Furthermore, 
Moore contended that structured guidelines were required to assure that patients received 
scientifically-based, ethical care. He first described these guidelines in 1965. The guidelines were 
meant to assure that patients and families would be provided with scientifically validated 
information, allowing them to participate in making informed decisions about their clinical care. 
Additionally, credible information would assure that the patient’s care would be delivered from 
highly skilled doctors, nurses, and other well-trained personnel. The guidelines encouraged 
extensive laboratory work and required that such work, along with the patient's progress and 
experience, be documented and available for scientific and public critique (Moore, 1965). These 
guidelines were further refined and outlined in several of Dr. Moore's subsequent publications. 
Moore refers to them as “Ethical Criteria for Surgical Innovation" (1970, 1988, 1989, 2000). 
        Ethical and scientific discussions were abundant during the conceptual phase of facial 
transplant surgery; both in support (Alexander et al., 2010; Kalliainen, 2010; Morris et al. 2007) and 
against (Kalliainen, 2010; Morris et al., 2004; Strong, 2010). The discussions included debate on 
issues of patient autonomy, ability to obtain informed consent, and the technical skills of the teams 
undertaking the procedure. Therefore, utilizing Moore’s framework to consider the ethical 
acceptability of facial transplant surgery, as understood by health care team members involved in the 
patient’s care, is appropriate. 
The Major Components of Moore’s “Ethical Criteria for Surgical Innovation” 
       Dr. Moore defined criteria to evaluate the ethical acceptability of an innovative 
procedure or technique (1965, 1970, 1988, 1989, 2000). The criteria for evaluation he described are 
portrayed in Figure 1:  
 the scientific background of the innovation, 
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 the skill and experience of the team (“field strength”),  
 the ethical climate of the institution,  
 open display and public and professional discussion and evaluation” (Moore; Wiggins et 
al., 2004, p. 7)  
Moore’s Ethical Framework for Surgical Innovation
• Adequate laboratory and clinical evidence
• Well-defined knowledge & skill requirements
Scientific 
Background
• Evidence of resources to support complex 
patient needs
• Availability of multi-disciplinary trained 
teams 
Team Skill & 
Experience
• Institution displays a philosophical stance 
based in the basic ethical principles
• Fundamental unease about undertaking the 
innovation exists
Institutional 
Climate
• Ongoing transparent discussions
• Assessment of scientific integrity
• Guiding motivations focus on positive 
patient outcomes
Public & 
Professional 
Critique
 
 Figure 1. Moore’s Ethical Framework for Surgical Innovation (1965, 1970, 1988, 1989, 2000). 
Scientific Background of an Innovation. Substantive scientific laboratory work undertaken in 
the development of an innovative procedure is a critical component to consider when evaluating 
the potential success of a therapeutic innovation (Moore, 1965, 1970). Credible scientific 
evidence provides a means to quantify the statistical likelihood of a positive outcome and 
outlines the knowledge and skill necessary to assess the feasibility of the endeavor (Moore, 
1965, 1970). This evidence is generally a result of extensive laboratory work or results of 
clinical trials (Moore, 1965, 1970).  Importantly, as in the case of facial transplantation, where 
the sciences of transplantation, reconstructive surgery, and immunology have guided 
development of the innovation (Pushpakumar et al., 2010), the patient’s care must be grounded 
in previously successful, well-developed, medical and surgical processes (Moore 1965, 1970).  
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   Skill and Experience of the Team: “Field Strength.” The “Field Strength” necessary to 
assure ethical acceptability of an innovation is evidence of the knowledge, training, and 
experience of those undertaking the innovation. Easily validated from within the medical arena, 
“field strength" may not be immediately visible to the lay public (Moore, 1970). Specifically, 
complex innovations must be undertaken with the support of diversely trained multi-
disciplinary teams in clinical centers which support complex patient needs, as in the case of 
facial transplantation (Siemionow & Gordon, 2010a). Moore contended that “field strength” can 
exist even if the specific procedure has not been previously attempted; when the skill-set and 
expertise of the team has been demonstrated and documented during procedures utilizing 
transparent transferable skills and in laboratory settings (Moore, 1970). 
   Ethical Climate of an Institution. According to Moore, the criteria of greatest 
importance is the "ethical climate of an institution" (1970). Dr. Moore believed that the 
reputation of the institution for sound clinical practice and ethical care was paramount (1970, 
1988, 1989, 2000). In instances of a desperately ill patient, when the excuse is made that the 
patient was so desperately ill that the medical team had to try "something" warned Moore, a 
high suspicion for questionable ethical behavior is warranted (1985, 1989). Additionally Moore 
advised, "when the epiphenomena of medical care such as capital gain, investor profit, 
institutional reputation, fame, surgeon ego, municipal pride, and chauvinism become the true 
object of the procedure, then the ethical climate of the institution is no longer acceptable for 
therapeutic innovation" (Moore, 1988, p. 1064).                                                 
    Open Display and Public and Professional Discussion and Evaluation. The final 
criteria for consideration when determining the ethical acceptability of a surgical innovation is 
the extent to which the procedure has been scrutinized by both the professional community as 
well as the general public (Moore, 2000). Open forum discussions regarding the perceptions of 
the scientific integrity and background of the innovation, the necessary skill set of the team, and 
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the institutional motivation for the undertaking, assures the patient's best interest remains the 
primary goal (Moore, 2000). Moore noted that although absolute consensus may not be 
garnered, opportunities to address scientific and ethical questions and allow for healthy debate 
on these issues is of utmost importance (Moore, 2000). 
Innovation in Medicine Utilizing Moore’s Criteria 
The "Ethical Criteria for Surgical Innovation" outlined by Frances Moore has been 
effectively applied during for the development of innovative surgical programs (Magnus, 2010; 
Wiggins, 2004). Specifically, the University of Louisville applied the criteria during the 
conceptual phase of their facial transplantation program (Wiggins, 2004). 
 In addition to Moore's criteria however, the University of Louisville considered the 
following four additional criteria in determining the ethical acceptability of a facial 
transplantation program.  
 Are any remaining uncertainties about the procedure resolvable through transferability of  
knowledge from other surgical procedures?  
 Is there a cohort of well-informed patients willing to undergo the innovative procedure?  
 Will the procedure have the potential to help other patients in the future?  
 Has institutional review board review and approval been obtained (Wiggins, 2004)?  
To date, the University of Louisville has not yet performed facial transplantation procedures. 
                       Another application of Moore’s criteria was at Stanford University, where the criteria were 
applied in ensuring that stem cell clinical trials proceeded in an ethical fashion (Magnus, 2010). 
Moore’s criteria were applied in unison with the International Society for Stem Cell Research 
guidelines and the California Department of Public Health Human Stem Cell Research Advisory 
Committee to ensure a “balance of protection and innovation” (Magnus, p. 276). Moore’s criteria 
have not been used as a framework for other empirically-based research activity. 
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Application of Moore’s Criteria for the Proposed Study 
The “Ethical Criteria for Surgical Innovation" (Moore, 1988) provided the framework for this 
study. Understanding the healthcare team member’s experience of involvement in facial 
transplantation helped to identify patient-related topics in need of further exploration, expand a 
narrow evidence-base, and suggest interventions to assure optimal patient outcomes. Describing 
their experiences also helped describe whether personal or professional ethical challenges are a 
consequence of involvement in this innovative procedure. Therefore, a framework which provides 
criteria for the evaluation of the ethical acceptability of facial transplant surgery was justified and 
provided direction for further staff education, team building, and research foci. 
 Importantly, Moore’s criteria for the ethical acceptability of a surgical innovation provided the 
language and focus of the study’s Specific Aims. Specific Aim 1 addressed the skill set and field 
strength of the healthcare team. Specific Aim 2 addressed the ethical experience of the healthcare 
team caring for patients involved in facial transplant surgery. Additionally, the concepts from the 
framework formed the basis for the content of the interview guide and questions used during the data 
collection phase discussed in Chapter 3. 
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Chapter 3 
Methods 
 
Introduction 
 This study used a qualitative descriptive design to explore the experiences of members of the 
health care team who have participated in facial transplantation procedures and patient care. 
Multidisciplinary team members, including professional, ancillary, and support staff, were invited to 
participate in individual interview sessions to elicit their personal and professional or occupation-
related experiences. Dr. Francis Moore’s “Ethical Criteria for Surgical Innovation” (1970, 1988, 
1989, 2000) guided this study. Moore’s framework deliberates: the scientific background of the 
innovation, the skill-set and field-strength of the team, the ethical climate of the institution, and 
extent to which the innovation has been subject to professional and public scrutiny (1970, 1988, 
1989, 2000). 
 The purpose of this chapter is to describe the research methods used in this study. The setting, 
sample selection, and procedures for data collection, management, and analysis are described. 
Additionally, procedures to assure trustworthiness and reflexivity are outlined. Finally, human 
subjects considerations addressed are discussed. 
Qualitative Descriptive Design 
An exploratory, qualitative descriptive study was undertaken. Qualitative description is a 
research approach within the naturalistic paradigm of inquiry (Sandelowski, 2000, 2010). This type 
of qualitative approach is useful when a comprehensive summary of an experience is desired; 
promoting rich description of real-life events without extensive theoretical or interpretive deduction 
(Sandelowski, 2000). The philosophical orientation of a naturalistic paradigm holds that there are 
multiple realities, that they are contextual, and that “constructed realities can only be studied 
holistically” (Lincoln & Guba, as cited by Thorne, Reimer Kirkham & O’Flynn-Magee, 2004, p. 5). 
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Importantly, as previous studies describing the experience of health care team members 
involved with facial transplantation were not available, the qualitative descriptive design allowed for 
an iterative process of modification of the interview questions as themes emerged during data 
collection and analysis.  
Setting 
 The study took place at Brigham and Women’s Hospital (BWH). BWH is a 793- bed affiliate 
of Harvard Medical School in Boston, Massachusetts. BWH is well-known for having performed the 
first successful kidney transplant in 1954.  BWH has performed 4 of the 17 face transplants 
performed world-wide to date.  
Sample  
 Qualitative description utilizes purposeful sampling (Sandelowski, 2000). Purposive sampling 
assures that the phenomenon of interest will be present in those participating in the study (Creswell, 
2007). Maximum variation sampling was considered and was particularly useful as it supported data 
collection from those experiencing the phenomenon of interest on a wide variety of levels (Creswell, 
2007). Sample size was determined by the extent to which new data collected became redundant, as 
recommended by Gallo & Dumas, (1996).                                                                                                                                
 A purposive sample of health care team members was recruited. Review of donor and recipient 
patients’ medical record identified the healthcare team members for the potential sample. A 
“snowball sampling” technique (Polit & Beck, 2004, p. 306) was also utilized. This sampling 
method was operationalized by asking participants to recommend other health care team members 
they felt had been instrumental in the care of a patient who had undergone a facial transplant 
procedure, or in the development of the facial transplant program. Additionally, familiarity of the 
researcher with many of the individuals who had been involved in facial transplant patient care 
supported recruitment. Efforts were made to assure that the participants were multidisciplinary and 
included professional, ancillary, and support staff. Sampling continued until common themes and 
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response redundancy was reached. It was anticipated that there would be 20-30 participants 
included, based on multidisciplinary healthcare team members identified in published case reports 
(Pomahc et al., 2011; Siemionow & Gordon, 2010a), and this estimate was found to be accurate.  
       Inclusion Criteria. The sample included: 
 BWH health care teams members directly or indirectly involved in a facial transplantation 
procedure or those having cared for a patient involved in a facial transplantation procedure 
including: professional, ancillary, and support staff 
 Health care teams members instrumental in caring for donor and recipient patients before, 
during, and after a facial transplant procedure not directly employed by BWH (e.g. 
employees of New England Organ Bank), or who no longer work at the facility but were 
employed at the time of a facial transplant procedure 
 BWH employees who did not have direct patient contact but were instrumental in processes 
related to a facial transplant procedure  
  Exclusion Criteria. The sample did not include: 
 Health care team members who had no direct patient contact or who did not participate in 
procedures or processes related to a facial transplant procedure   
            Recruitment. Potential participants were contacted in person, by phone or through email. A 
letter of explanation regarding the purpose of the study, its voluntary nature, and assuring 
confidentiality was distributed during the recruitment process. Every effort was made to include a 
representative of each role category of health care team member involved in facial transplantation 
patient care.  
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Data Collection 
 Institutional Review Board approval was secured prior to commencing data collection. A 
verbal informed consent agreement was obtained from each participant. A demographic data sheet 
(Appendix C) was distributed to and completed by each participant. No record of the names of 
individuals who were invited to participate but declined was kept. 
 Individual, private, semi-structured interviews were conducted with twenty-four 
participants in a private location at a time convenient to the participant and researcher. Two 
additional participant interviews were conducted via telephone; one due to the participant’s 
relocation from the study’s geographic area, and one due to complex scheduling issues. All 
face-to-face interviews, with the exception of one due to the participant’s request, were audio-
taped. The participant who requested not to be interviewed offered no explanation why they 
were hesitant to do so, even after being reassured that the interview would be confidential and 
anonymous. The length of each interview ranged from 22 minutes to 77 minutes, with a mean of 
42 minutes. Transcribed interview dialogue yielded 779 double-spaced pages of data.  
 Interviews were digitally recorded using two recorders to assure recording quality. The 
interviews were transcribed verbatim by a professional transcriptionist, who signed a 
confidentiality agreement prior to commencing transcription services. In addition to the core 
interview questions, probes were used to stimulate dialogue and promote understanding of the 
questions as needed, and additional interview questions and probes were added in an iterative 
process.  Given the exploratory nature of this study, sampling continued until response 
redundancy was achieved. Field notes were recorded during and after each interview by the 
researcher. Member checks (Lincoln & Guba, 1985) were utilized during the interview process 
to assure understanding of the data being presented and assure descriptive validity 
(Sandelowski, 2000).  
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       The interview questions were derived from the specific aims of the study, which reflected the 
concepts of Moore’s “Ethical Criteria for Surgical Innovation” (1965, 1970, 1988, 1989, 2000) and 
consisted of: 
Specific Aim #1: To describe the skill-set, attitudes and experiences of the multi-disciplinary health 
care team members who have been involved in facial transplantation surgery and patient care. 
 
Conceptual Area Main Question Probes 
Introduction Can you tell me about your experience 
caring for a patient involved in a facial 
transplantation procedure? 
1.   How many patients have 
you cared for? 
2.   Was the patient a donor  
or recipient? 
3.   How often did you care  
for the patient? 
 
 
4.   How did it feel being  
involved in such a  
procedure? 
5.   What emotions were you  
feeling? 
6.   Do you agree in principle  
with the procedure? 
Scientific  
Background 
Were you aware of any preparatory 
work that led to the actual start of the  
facial transplant program? 
 
1.  What information or  
training did you receive 
prior to caring for the  
patient? 
2.   Are there areas of  
education that need to be 
improved upon? 
3.  What do you se as the  
greatest risks to the  
procedure? 
4.  What should the patient 
criteria be? 
5.   Do you view facial  
      transplantation the same  
      way as you view other  
       organ transplantation?  
6.   Would you consider 
donating your face or  
that of a loved one? 
7.  What technical concerns  
             did you have? 
Skill-set/Field  
Strength 
Tell me about specialized training and 
 team members that you felt were 
1. What skills did you bring 
      to the team? 
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 critical to the care of this patient    
 population. 
 
 
Tell me about the functioning of the 
health care team for this patient 
population and what efforts may 
promote team cohesiveness and  
collaboration. 
1.  Did you feel prepared to  
care for the patient? 
2.  What other skills were 
integral to the patient’s 
care? 
3.  Did you feel a different 
ownership about caring for 
the patient than some other 
more routine procedure? 
 
 
Specific Aim #2: To describe the ethical impact on the multidisciplinary healthcare team members 
of involvement in facial transplantation surgery and patient care. 
Conceptual Area Main Question Probes 
Ethical climate of the 
 institution 
Tell me about any personal or 
professional ethical issues you may  
have considered before, during or  
after caring for the patient. 
1. Were you aware of any of  
the ethical concerns  
published in the literature? 
how did they impact you? 
2.  Were people discussion 
facial transplantation? 
3.  Are you aware of any  
ethical concerns others 
may have had? 
4. What concerns did you  
have? 
5.  Are your feelings now 
different than those 
prior to caring for the  
patient? 
6. Are you concerned that 
the procedure may be 
abused? 
Open display and  
Public discussion 
Was facial transplantation openly 
discussed and fairly portrayed by the  
institution? 
 
What do you see as next steps? 
1. What did you hear? 
2. Where did you hear it? 
3. Were you aware of anyone 
 who disagreed with the  
 procedure? 
4. Do you feel the patients 
were treated fairly? 
5. Did you view the facial 
transplant program as a  
public relations conduit 
for BWH? 
 
Table 1. Interview Questions and Probes 
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Data Management 
 Immediately following each interview, the audio-recording was listened to in its entirety 
and additional field notes taken to supplement those completed during the original interview. In- 
depth notes were recorded during the interviews conducted by telephone, as well as during the 
one face-to-face interview that was not recorded per the participant’s request. The audio 
recording of each interview was then downloaded to a password protected computer, and a copy 
created for the transcriptionist. Audio recordings were listened to a second time and cross-
referenced with the transcriptionist’s rendering. Transcribed interviews were then uploaded to 
NVivo software for coding and analysis. The notes from the two interviews conducted by 
telephone and the interview that was not recorded were also uploaded to NVivo, and when 
coded, contained a notation that the comment was paraphrased by the researcher. 
Data Security 
       Tape recordings, field notes, and all data materials will be maintained on an encrypted, 
password protected laptop computer. All data sources will be destroyed in five years. 
Data Analysis 
           Qualitative description data analysis takes place through inductive processes, establishing 
patterns and themes (Creswell, 2007). Deep interpretation of data by the researcher is not done with 
this approach as the value of the data collected is the rich description of the experience in the 
participant’s own words (Sandelowski, 2000, Sullivan-Bolyai et al., 2005). Conventional qualitative 
content analysis (Hsieh & Shannon, 2005) and constant comparison (Sandelowski, 2000) was carried 
out throughout the interview and data analysis phases. Conventional content analysis is appropriate 
when there is little know about the phenomenon of interest (Hsieh & Shannon, 2005), as was the 
case in this study. Analysis occurred at the individual participant level, as well as at the inter-
disciplinary and intra-disciplinary levels. Hence, the analysis identified themes within the individual 
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experience and between participants to contextually describe the whole of the phenomenon (Ayers, 
Kavanaugh, & Knafl, 2003). 
        Miles and Huberman (1994) outlined a series of steps to be undertaken during qualitative 
content analysis. These steps are: (1) coding of the data from field notes and observation, (2) 
recording insights and reflections on the data, (3) identifying similar phrase, patterns, and themes, 
(4) looking for commonalities in the data, (5) making generalizations, and (6) examining these 
generalizations in relation to what is already known about the phenomenon. The analysis was 
supported and summarized using descriptive statistics to further clarify specific phenomena of 
interest (Sullivan-Bolyai et al., 2005), including the number of participants who agreed in principle 
with the procedure or would consider donating their own or a loved one’s face.           
 The analysis processes described by Miles and Huberman (1994) is supported by the NVivo 
software. Additionally, the NVivo software aided in the conceptual organization of the data, 
allowing queries to be made of the data, and graphically model the emerging ideas, concepts, and 
relationships (Bazeley, 2010). The data was re-presented in a variety of ways to promote clarity in 
analysis of the findings.  
 At the outset, a series of broad coding categories were created which aligned with the 
major concepts of the study’s framework: Moore’s “Ethical Criteria for Surgical Innovation” 
(1970, 1988, 1989, 2000). These codes included: scientific background, field strength, ethical 
climate of the institution, and open display and discussion of the surgical innovation. Similarly, 
other coding categories were initially created which reflected themes extracted from prior 
empiric work on the topic.  Importantly, these empiric works were completed during the 
conceptual phase of facial transplant surgery, as no prior study has explored the experience of 
the health care team who has cared for this patient population.   
 Though a series of broad coding categories were created a priori, the majority of codes 
emerged, were constructed, and continued to be defined throughout the data collection process. 
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Effort was made to code each interview within a tight timeframe to when it had occurred, 
allowing for emerging themes and subthemes to be incorporated into subsequent interviews. 
The process of code creation and analysis was an iterative process using inductive and 
deductive reasoning skills, thereby promoting refinement of the study questions prior to 
subsequent interviews. Additionally, this process assured a flexible design supporting the 
identification of emerging themes. Themes and subthemes were reviewed multiple times for 
accuracy, and expanded or consolidated as necessary to promote clarity, reliability, and validity 
of the coding categories. Themes constructed during data analysis sought to underscore the data 
using descriptive terminology, as is the focus of the study’s qualitative descriptive design.  
Trustworthiness 
        The trustworthiness (Lincoln & Guba, 1985) of qualitative research is a major consideration 
when evaluating the value of research findings. In qualitative description, as in other approaches to 
qualitative research, the investigator serves as the “research instrument” and has a personal and 
professional responsibility to assure that the research process is ethically sound.  The data collected 
must be a true representation of the participant’s intent. Four dimensions to consider when 
evaluating the trustworthiness of qualitative research are: “credibility, dependability, confirmability, 
and transferability” (Lincoln & Guba, p. 328).  In this study, efforts were made to assure 
trustworthiness as defined by Lincoln & Guba (1985). 
   With the qualitative description approach, a rich description of a phenomenon in the 
participant’s own words is sought; hence the dimension of credibility is particularly important. 
Credibility is the measure of confidence that the findings reflect “truth” as understood and expressed 
by the participant.  Activities to support credibility in a qualitative descriptive study are peer- 
debriefings; having another researcher evaluate the data for agreement of findings, and member 
checks; affirming with the participants what the researcher “heard” as the data was collected 
(Lincoln & Guba, 1985). A colleague with a Doctoral degree in Nursing and an extensive program 
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of research served as a peer debriefer for this study.  Member checks (Lincoln & Guba, 1985) were 
utilized during the interview process for clarification, and subsequent to the interviews (n= 6), for 
verification of data. There was also an independent review and coding of 8% (n=2) of the transcripts 
by the dissertation committee Chair, Dr. Susan Sullivan-Bolayi. 
        If the criteria to determine “credibility” are satisfied when evaluating a study, an assumption 
might be made that the results of the study could also then be termed “dependable” (Lincoln and 
Guba, 1985).  Dependability denotes that the findings would be replicated by another researcher if 
the study’s design and participants remained the same (Lincoln & Guba, 1985). Lincoln and Guba 
suggest this may be the case, but also urge further activities to substantiate the determination of 
dependability. A suggested activity for use with the qualitative description approach is a 
dependability audit (Lincoln & Guba, 1985). The auditor, who ideally is a content expert in the 
subject matter, critically and objectively evaluates the methods, data, and conclusions for 
concurrence with the study’s findings, believability, and consistency. Dr. Bohdan Pomahac, lead 
surgeon for the BWH facial transplant program served on the researcher’s dissertation committee 
and as such, evaluated the dependability of the findings. In qualitative descriptive research, the 
dependability audit also fulfills the tenets of confirmability (Lincoln & Guba). 
          The transferability of findings, the last component of trustworthiness as defined by Lincoln 
and Guba (1985), is not an inherent goal of qualitative descriptive research. Data collected through 
qualitative description are a rich description of an experience rather than deep, thick interpretive 
details of a participant’s experience and need not be directly transferable to other situations.                                                                                                                         
Human Subjects Considerations 
      IRB application process. An application was submitted to the BWH IRB and approval to 
undertake the study was obtained. A copy of the application and an Institutional Authorization 
Agreement was drafted between the BWH IRB and the University of Massachusetts Medical School 
IRB.  
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      Protection of human subjects. An initial sample was identified through review of the facial 
transplant patients’ medical records and each potential participant received a letter of explanation 
about the study during the recruitment phase. A verbal informed consent was obtained prior to 
commencing the individual interviews. Additional participants who were instrumental in the care of 
a facial transplant patient, and nominated by those enrolled in the study after the investigator’s 
review of the facial transplant patients’ medical record, were also asked to participate. Contact 
information was obtained from the hospital’s staff directory. All potential participants received 
reassurance that they were free to decide whether or not they wanted to be included, and that 
regardless of their decision, that they would remain anonymous. Demographic data is reported in 
aggregate to protect the anonymity of the participants. In addition, any potential personal identifying 
descriptors were omitted during the discussion of the findings in order to protect the participants. 
Prior to the start of each interview, the investigator reassured participants that their participation was 
voluntary, confidential, and that they could choose to end the interview questioning at any time. 
       There were no anticipated physical or emotional risks to the participants. In the event that a 
participant became emotionally upset during the interview process, a referral would have been made 
to the BWH Employee Assistance Program (EAP). Contact information for EAP services was 
provided in writing to each participant at the end of their data collection session. Additionally, the 
peer debriefer and the investigator’s dissertation chair would have been made aware of any 
troublesome emotional reactions of the participants. 
 A token of appreciation was given to each participant by the investigator at the completion of 
their interview. The token was a $15.00 gift card to a local restaurant located on the hospital campus.  
         Reflexivity.  Reflexivity is the conscience disclosure of biases, values, and experiences of the 
researcher that may influence the study’s results (Creswell, 2007). The investigator has more than 30 
years experience as a perioperative nurse and has participated in multiple organ procurement and 
transplantation procedures. Additionally, the investigator was involved in the intraoperative care of 
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the donor patient of the first facial transplant procedure performed at BWH, however is no longer a 
member of the operating room staff. Therefore, it was critical to be transparent and open to any 
potential biases that might occur during the interviews and data analysis. The investigator in this 
study assured reflexivity through personal reflexive journaling throughout the study. Included in this 
journal are extensive details about the schedule, logistics, and methodology used during data 
collection (Lincoln & Guba, 1985) and personal thoughts and experiences that could potentially 
influence the findings. The reflexive journal was discussed regularly with the peer debriefer and the 
Chair of the investigator’s dissertation committee.          
Chapter Summary 
 This study utilized a qualitative descriptive method to explore the experiences of the health 
care team members who had cared for patients involved in facial transplantation surgery. Data 
collection occurred through individual,  multidisciplinary interviews. The sample was identified 
through review of a medical record of patients involved in facial transplant surgery and through a 
snowball technique. Qualitative content analysis occurred throughout data collection by the 
investigator utilizing the process outlined by Miles and Huberman (1994) and with the support of 
NVivo software. Efforts were undertaken to assure trustworthiness and human subjects protection.  
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Chapter 4 
Results 
Introduction 
 A qualitative descriptive approach was used to explore the experience of the health care team 
involved in facial transplantation surgery and related patient care. The purpose of this chapter is to 
report the study findings. Two main themes, “individual sense of purpose” and “esprit de corps,” 
emerged from the data.  “Individual sense of purpose” describes the meaning of the experience that 
involvement in facial transplantation had for the participants and is comprised of three subthemes: 
“getting it right” (a vigilance to be attentive and thorough in providing care to assure a positive 
outcome), “transforming a life” (an empathic realization of the profound life-changing possibilities 
of the procedure) and “spirituality” (a heightened awareness of marvel and awe as a consequence of 
participation).  The theme “Esprit de corps” conveys the morale of the health care team members 
involved in facial transplantation and was expressed through three subthemes: “leadership” (trust in 
the altruistic motivations of the lead physician), “teamwork” (a respectful acknowledgment of the 
critical contributions of each member of the health care team) and “environment” (the social, 
intellectual, and historical architecture which supported innovation at the institution). The themes 
and subthemes are depicted in Figure 2. 
  
Figure 2. Themes and Subthemes 
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Sample 
 A total of fifty-two participants were contacted and invited to participate. Twenty-six 
individuals (50%) responded, consented to participate, and were interviewed. Of those who were 
invited but chose not to participate, most (n= 25) simply ignored the invitation. One participant 
responded that she felt others may be more appropriate to participate but did not elaborate. Data 
collection occurred between October, 2011 and December, 2011. 
 Demographic data including age, gender, race, health care team role, number of years working 
in the discipline, and highest academic degree held were collected and reported in detail in Appendix 
D. The mean age of the participants was 47.4 years (SD = 9.2; range = 26 to 63). Seventy three 
percent (n=19) were female, 27% (n=7) were male. Ninety-six percent (n= 25) were white, 4% (n=1) 
was Asian. The health care team members classified by role group included:  34.6 % (n=9) nursing, 
19.2% (n=5) medicine, 27% (n=7) clinical support services (occupational therapy, speech therapy, 
physical therapy, nutrition, social work, and representatives of the New England Organ Bank) and 
19.2% (n=5) patient care support services (administrative support, surgical technology, patient care 
assistant, security department representative, and a member of the public affairs staff). The 
participants had an average of 18.3 years of experience in their current discipline. (SD = 10.6; range 
= 4-37). The highest level of education attained by the participants was: 7.7% (n= 2) high school 
diploma, 3.9% (n= 1) associate’s degree, 23% (n= 6) bachelor’s degree, 38.4% (n=10) master’s 
degree, and 27% (n=7) doctoral degrees. The majority of the participants (53.9%, n= 14) had cared 
for four facial transplant patients, 11.5% (n=3) had cared for three patients, 19.2% (n= 5) had cared 
for two patients, and 15.4% (n=4) had cared for one patient. Other demographic data collected, 
including religious background and self-identification of being or not being a spiritual person, will 
be discussed in a subsequent section of this chapter. 
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The Experience of the Health Care Team Members Involved in Facial Transplantation 
Surgery and Related Patient Care 
 The healthcare team members involved in facial transplantation surgery readily shared their 
attitudes and experiences. Almost all of the 26 participants (n= 23) had spent considerable time prior 
to and following the procedures reflecting on their professional role in caring for this patient 
population with their discipline-specific peers. Additionally, participants shared thoughtful 
individual and personal reflections with emotion, passion, and sincerity. There appeared to be little 
hesitation on the part of the participants to answer questions honestly and with candor. Some 
admitted to reflecting more intently about involvement in the procedure and its implications during 
the time between their invitation to participate and their actual research interview. Several (n= 8) 
articulated appreciation for the opportunity to present their feelings in a "cathartic" way. 
 All participants had been exposed to other organ transplantation procedures as well as 
other innovative procedures during their professional careers. Most (n= 21) maintained that 
facial transplantation had a very different gestalt than the other organ transplant patient care 
with which they had been involved. More importantly, they contended that the experience of 
this innovative procedure, compared to other innovation they had been part of, “reached another 
level.” As participants sought to describe this “other level” of experience, several (n=8) used 
the word “awe,” while others (n=4) described it as “surreal.” One participant said, “people can 
say what they want- it's just another part of your body, like for people to give a loved one a 
kidney. But it's way beyond that. Way beyond that.” This sentiment was reiterated many times 
and in many forms. Some participants described facial transplantation as being of greater 
magnitude than vital organ transplantation as “this operation transform(s) the patient's life and 
really change(s) the experience of being a human being.” One participant said that though he 
did not view facial transplantation different from a science or mechanical view point, from the 
non-scientific standpoint it was "uncharted waters."  
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 The most frequently used words to describe the experience were: “amazing, awe-inspiring, 
challenging, exciting, exhilarating, fascinating, hopeful, inspiring, interesting, and rewarding." 
Some participants also used the words “nerve-wracking” and “frustration” when describing the 
experience, specifically in situations where they felt unable to adequately anticipate some aspect 
of the patient’s care given the innovative nature of the procedure. Phrases used by the 
participants to describe the experience were: "A breathtaking experience,” “pushing the 
envelope,” “being on the cutting edge,” “kind of the blast,” “an incredible opportunity,” and 
“totally surreal.” One participant described the experience in this way: “really awe inspiring.  I 
mean, it's unbelievable to be in the room.  You can hear, especially with the first one, the gasps 
when it happens.” Another said: “I think it was just surreal, just kind of surreal.  And people 
said it was the best thing they've ever been involved in.” Interestingly, despite describing the 
experience as “awe-inspiring” and “surreal,” only a few (n= 3) admitted to having early 
skepticism about whether the procedure would actually ever take place, and no participant 
expressed opposition to the procedure in principle.  
Individual Sense of Purpose 
 An “individual sense of purpose” was generated for the participants as a result of being 
involved in facial transplantation patient care and is representative of the multidimensional 
meanings that the individual health care team members described regarding the experience. The 
individual participants described a seriousness of effort (subtheme: “getting it right”), conveyed 
a commitment to assuring successful outcomes for patients (subtheme: “transforming a life”) 
and, for many of the participants, resulted in extensive personal reflection and a heightened 
sense of awe (subtheme: “spirituality.”) 
 Overall, the participants expressed extreme pride (13 instances) and intense honor (16 
instances) at the opportunity to be involved in a facial transplantation surgical procedure or 
participate in the related patient care. Several cried during their interviews. Most participants 
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were passionate about having had the chance to do “important work” which one person 
described as “so out front of what is being done in medicine right now.”  
 Getting it Right. A subtheme that emerged from the theme Individual Sense of Purpose was 
Getting it Right.  Clinical participants (n= 23) expressed confidence, despite the challenges inherent 
to the innovative nature of the procedure, that their prior experience caring for other complex 
patients- including patients who had undergone solid organ transplants, free-flap reconstructive 
procedures, or had suffered  severe burn injuries- readied them to care for patients receiving a facial 
allograft. Most clinical participants (n= 22) were regarded as senior level practitioners in their 
disciplines and responsible for, as one practitioner explained, “the higher level acuity patients.” Each 
therefore believed that they had been likely selections for involvement in the innovation. Not only 
did they exhibit the knowledge and skill set required to provide care to this unique patient 
population, they also exhibited qualities of being forward-thinking (“we're educated risk-takers”), 
passionate about their work (“this speaks to the notion of us constantly wanting to try to figure out 
better ways to take care of unsolved problems”), and likely “best in class” in their discipline (“these 
cases are the most difficult, most time consuming, with lots of brilliant people involved.”) 
 Several of the participants described the planning process and the implementation of care for 
this patient population as requiring a comprehensive skill-set; one that encompassed all technical and 
scientific knowledge specific to their discipline. They described this patient population as needing 
collectively intense physical, emotional, psychological, and spiritual care in contrast to other patient 
populations where one realm of care is often dominant. One nurse said: “it really brought me back to 
the basic foundation of nursing in -- in an incredibly meaningful way.” 
 Concurrently, all clinical participants expressed an overwhelming feeling of responsibility to 
“get it right.” One health care team member described the “heaviness” of her responsibility as: 
 I went to the literature and tried to see, you know, what should be in our profession's 
guide to practice.  And so, I had to really do a lot of exploration of just what I should be 
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doing.  And I felt like -- I felt a little bit of a weight on my shoulders that if I didn't really 
look into this and get it right-- I didn't want our discipline's role to not be explored. 
A number of participants who provided care during the postoperative phase expressed great 
“weight and worry” that they may miss a physical warning sign and be responsible for the graft 
failing. One participant said; “this was really quite weighty.  And it made me think a lot about 
the responsibilities, and the licensure, and the preparation of people.” Participants reported this 
“weight and worry” as an exaggerated emotion when compared to caring for patients 
undergoing other innovative procedures. Some believed that this was likely due to the 
intricacies of the human face’s physical and emotional qualities. Others attributed the emotion 
to feeling a profound level of commitment to the donor’s family. One participant described her 
reaction as “it's such a gift that the donor family is giving somebody that you want to make sure 
that you do what you can, as much as you can to make sure that that gift goes through.” 
 Participants described thinking about the procedure and worrying about the patients even when 
they weren't at work. Most believed that this was due to the innovative nature of the procedure and, 
moreover, due to not having well established care protocols in place to guide their practice. 
Additionally, they believed this reflected their realization of the great emotional impact of the 
procedure on the patient, and hence on members of the health care team’s desire for a positive 
outcome. Most who reported early fear and worry recounted that these feelings subsided with 
subsequent patients and reported a “de-escalation of emotion” due to evolving skill. 
        Though the clinical practitioners expressed a high level of confidence in their ability to 
care for the multiple physical needs of the patients, many expressed individual hesitation and 
uncertainty about “getting it right” when addressing the issue of the “new” face with the 
patients. In approaching one patient about their reaction to their new face, one nurse said:  
“…you tread on that …you know, do you -- should I, or shouldn't I ask this question?” Many 
practitioners did not feel ready for this conversation. One nurse explained “things that would 
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come up in conversation were just kind of odd to talk about.” Additionally, few clinical 
practitioners felt prepared to handle the issues of identity with the patients should they arise. 
One nurse rationalized this concern saying “I would hope by the time that they get to us that 
they have received psychological counseling.” 
 Transforming a Life. The second subtheme linked to the theme Individual Sense of 
Purpose was Transforming a Life. As a whole, the participants believed that successful facial 
transplantation surgery had the potential to positively “transform the life” of the recipient. A 
participant recounted witnessing one patient’s transformation in this way: 
        The first time I met him I thought, "Oh, my God.  You cannot have a normal life.  The way 
that you look, there's no way that you can have a normal life, because nobody can ever -- 
when you walk down the street, nobody's ever going to react to you in any normal way."  
And I felt awful for him.  And to be able to see him have the face transplant, and then talk 
to him more than a year later when he came back for something else. And that was a 
wonderful experience; he actually extended his hand for the first time to me.  Before, he 
didn't want to talk to anybody.  He would just look away. And he extended his hand.  And 
he didn't know who I was.  He didn't remember ever seeing me before.  And he was happy 
to meet me.  We had a wonderful conversation.  He laughed.  And he interacted with me 
the way most normal patients would.  So, it was good for me to see that, because I saw 
how he had changed over a couple of years, with the face transplant in between. 
 All participants perceived the patient’s pre-transplant lives to be “unbearable” and several 
of the participants involved in the patient’s clinical care expressed desperation to transform the 
lives of those who have severe facial disfigurement accompanied by mechanical and functional 
deficits. Importantly, the participants acknowledged life-altering cosmetic post-operative 
outcomes for the recipients and were optimistic about successful functional and mechanical 
outcomes as well. Additionally, the participant’s spoke about the transformation that must have 
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occurred within the donor’s family when making such a “precious and incredible gift,” and 
some participants expressed a transformation of their own thinking as a result of involvement. 
        Perceptions of Patient Transformation. Three categories within the subtheme 
“transforming a life” arose in regards to the transplant recipient patients: the perception of the 
patient’s pre and post-operative life experiences, the perception of their personality traits and 
potential impact on surgical outcomes, and perceptions on the process of patient selection. 
Patient selection received extensive attention by the participants, seemingly indicative of the 
recognition of the vast transformational potential of the procedure. 
        Perception of the patient’s life experience. The participants expressed great empathy 
toward those in need of a face transplant. They were able to discern that these patients had 
significantly disfiguring injuries which resulted in a very real need for surgical intervention to 
improve mechanical and functional outcomes.  Additionally, the cosmetic benefits of the 
procedure were viewed as essential for the patient in order to live any semblance of a "normal” 
existence. One participant summarized it as: 
The people who say a heart transplant is lifesaving, but a face transplant is not, 
have never suffered a burn injury.  They've never suffered a disfiguring injury, 
because anyone who has wouldn't say that.  And to walk around with such a visual 
injury 24 hours a day, your entire life, is horrific.  I'd much rather have a heart 
condition… 
 Some participants sought to describe a link between emotional identity and the appearance 
of a person's face. In many instances this was a difficult undertaking, in part because of the high 
level of emotional reaction which it elicited. One participant summarized it as, “the face, in 
particular, is such an emotionally charged organ that when it is disfigured, it is -- it is very -- it's 
a profound experience for the patient who experiences it.  But it's also kind of a profound social 
experience for anybody who meets that patient.” 
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 Many participants spoke of the overall success of the transplants to date and that to their 
knowledge, each patient seemed satisfied with the outcomes. Some worried that all outcomes 
may not be as positive and cautioned that the long-term outcomes are unknown. Others 
discussed the logistical issues such a transformation brings; such as past photos, blended hair 
color, media attention, and the patient’s ability to be recognized in public and wondered if the 
patient had adequate supports in place to help them work through these issues.  
 A few members of the health care team were concerned about the effect that the surgery 
might have on the patient’s identity and “sense-of-self.” More commonly however, participants 
dismissed these concerns as less significant citing that these patients were accustomed to a 
whole array of unusual problems and reactions from others due to their appearance. One 
participant viewed it as “restoring” the individual’s identity rather than complicating or 
replacing it.  
 Perception of facial transplant recipient personality traits.  In general, the facial 
transplant recipients were described as “resilient” and “courageous” individuals by the research 
participants. They were also described as “inspiring risk takers” who sought to better their own 
lives but who also contributed to the betterment of society in a tangible way.  “There's an 
undervaluing of the contribution to society that's made through these initiatives” one participant 
said. 
 Some participants, who knew several of the patients pre-operatively as well, characterized the 
patients as possessing similar personality traits. This was described as a balance of resilience and 
acceptance of their injury which had allowed them to continue to live their lives despite their 
disfigurement, with an unwillingness to accept that their lives could not be transformed for the 
better. Others however, cautioned that the risk taking personality trait which seemed inherent to 
several of the patients may have contributed to the incidences that so severely injured them in the 
past, and worried how this propensity may impact their long-term outcome. This was visibly 
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disturbing to those who articulated it and many had great feeling and emotion as they discussed the 
psychosocial backgrounds of the patients selected. 
 Perceptions of patient selection. The topic of patient selection for the procedure elicited 
extensive discussion. Several participants were hesitant to approach the topic even when prompted, 
while several others asked “permission” to discuss it. Two requested that their comments be kept 
"off the record." 
  The psycho-social background of some of the patients was discussed by many of the 
participants and they questioned the impact of it on potential outcomes. They reported robust 
conversations on the topic with their colleagues. In some instances, it was difficult for the participant 
to articulate why the patient selection criteria for this particular procedure should receive such great 
emphasis as compared to other procedures, including other organ transplantation. Others speculated 
that the procedure had been worthy of a “different level of scrutiny” than other procedures because 
of the “sacrifice” of the donor’s family.  In other instances, the participants asserted strong 
sentiments about the cognitive functioning, social and psychological stability of the patient that 
should be required for the procedure to be undertaken. In particular, two participants strongly 
believed that these criteria should play the defining role in establishing candidacy for the procedure. 
Many other participants reported having similar views in the early stages of the procedure and that 
extensive discussion with and among their colleagues on this matter were common. They identified 
the topic as “controversial” and generally theorized that it was because of limited resources, the 
“ultimate gift” of a face, and the financial liability of the procedure and subsequent treatment. Most 
significantly, they reported that the conversations amongst their colleagues contained a constant 
premise and included judgment or bias regarding the nature of the patient's injuries, their psycho-
social support systems, and in some cases, the history of risky behavior.  
 Despite these opinions, the majority of the participants were aware of the extensive screening 
process undertaken and stated that they “just had to trust” those making the decision regarding 
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patient selection. One participant asserted a philosophical opposition to "playing God in morally 
ambiguous situations.”  
 One other topic regarding patient selection that arose was that of blind patients undergoing 
facial transplantation surgery. Again participants reported robust conversations among their 
colleagues regarding patient selection if a patient was blind. Overall, participants believed that blind 
patients were as appropriate for the operation as patients with sight as blind patients could perceive 
others' reactions to them and therefore their social interactions would be equally enhanced by 
undergoing the transplant. A few participants believed that blind patients may be more appropriate to 
receive a facial transplant as a mechanism of support for social interaction. 
 Perceptions of Potential Donor Family Transformation. In discussing the 
transformational potential of the surgery, several participants reflected deeply about the 
“precious and incredible gift” that the patients had received. They expressed hope that the gift 
was positively transformative to the donor’s family as well and pondered whether they could 
make such a decision. They viewed the patients as having had received a gift of infinite 
proportion. 
 Most participants believed that donation of a loved one’s face was a “gift” far 
beyond that of a solid organ and expressed “a tremendous amount of respect for the 
families that are willing to have their loved one give that kind of a gift.” The participants 
who had cared for one of the donor patients, many of whom had developed longstanding 
relationships with their family, found the experience to be exceedingly emotional. This 
was most often described simply as "sad.” The most frequent reaction expressed by the 
participants regarding the family’s consent to donation however, was “disbelief.” 
And I really sat there and thought, ‘Oh, my gosh.  I can't believe this.’  And all 
the things I thought about before, how much that people had to give up, that the 
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donor had to give up, and how great the family was to donate the face.  And I 
thought about, ‘How could the family make that decision?’  
 Many participants expressed similar sentiment and thought that it would be very difficult for 
families to donate a loved one's face. They were concerned that the impact this may have on future 
efforts. Several noted that our society’s norm of “viewing” the deceased after death may diminish 
the availability of facial tissue donors.  
 Interestingly, though the vast majority of participants supported facial transplantation in the 
theoretical sense, many were unable to readily answer the question about donating their own face or 
that of the loved ones. Of the 19 participants who had reflected enough on the question of donating 
their own face, 58% (n= 11) said yes. The remaining 42% (n=8) said no. Perhaps even more striking 
were the responses to the question regarding donation of a loved one's face. Of the 17 participants 
who addressed this question, only 29% (n=5) said yes. The remaining 71% (n=12) had extreme 
difficulty in conceptualizing such a donation. Despite their active involvement in caring for this 
patient population, most of the participants acknowledged not having yet had in depth conversations 
with their family about the topic.  
 Perceptions of Health Care Team Member Transformation. Many participants described 
personal transformations as a result of involvement in facial transplantation. They reflected on the 
transformation of their personal judgments and biases and those made by other members of the 
health care team. Most participants who admitted that they had expressed reservations about the 
patients selected for facial transplantation surgery were subsequently introspective about prior 
judgments however, and only a few participants continued to have reservations about at least some 
of the patients selected, and two adamantly so. Many expressed that some of the patient outcomes 
were significantly better than they would have anticipated. One participant reflected on her early 
opinions and said: “I think, personally, it helped me learn to be careful of your judgments; and to 
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just try and stay more neutral until you have all the facts, and find out and question things before you 
form an opinion.” 
 As one of the participants attempted to explain his personal experience, he said: “these 
patients speak to us at a very, very core, fundamental, profoundly human level.”  As such, an 
attitude of "how can we not try this" resonated throughout many of the interviews. Many of the 
participants expressed joy in contributing “even a small role in transforming a life” and others 
believed that they had been “involved in something very special.” Moreover, when discussing 
their experience and contribution to the effort, many of the health care team members said that 
there was a strong spiritual component to the work. 
 Spirituality. The third subtheme linked to Individual Sense of Purpose was Spirituality. 
Self identification of spirituality and religious background of the participants was collected on 
the demographic questionnaire. Reponses to the question “do you consider yourself a spiritual 
person” were: 19 participants said yes, 4 participants said no, 1 said sometimes, and 2 did not 
answer the question. Religious background data were: 80.7% Christian, (n= 21), 3.8% Jewish 
(n=1), 7.7% Christian & Jewish (n=2) and 7.7% responded “none” (n=2). Five of the 
participants also added “non-practicing” or “atheist” after their religious background 
designation. 
 Twenty-two participants (84.6%) reflected on the impact that involvement in the procedure 
and/or subsequent patient care had on their spirituality. Sixteen (73%) reported a spiritual 
component to the work, while six (27%) related no spiritual component. Overall, the healthcare team 
members involved in the intraoperative care of the patient (n= 8) expressed a poignant spirituality to 
the experience (n=7; 88%). This was most often related to the transformation of the patient; 
including the understanding of witnessing the transfer of a “God-made part” from one human being 
to another. There was consistent description (one exception) with being present in the operating 
room and viewing the experience as spiritual.  
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 The experience of being in the room, having them roll into the OR with this injury, and 
then roll out with a face again is an amazing experience that is beyond just the kind of 
surgical intrigue and technical wonder of -- that we can do this, which is a whole separate 
topic.   
Another described the intraoperative spiritual impact in this way: 
Like it's an -- it is one of the most amazing things when the face is first draped over 
the recipient, and you see this -- you see them become humanized again, in a way.  
And so, that whole process of seeing the patient transformed is a very -- it is a very 
emotional, spiritual experience. I'm not really a religious person.  But it's a -- it is the 
closest that I feel to some sense of religion in what we do. 
Another described the moment of revascularization of the facial graft:  
 And that sheer moment when you've -- when you've procured the part, you've 
washed out all the blood out of it with the very, very cold solutions that we use -- 
And it's really -- it looks like white marble. And then you bring it to the -- to the 
recipient, and you join up the first blood vessels, and let the clamps go, and watch 
that thing come to life.  That is a real surreal moment to see that happen, that sort of 
wave of life just coming to that part; realizing, at the same time, that the donor is -- 
has expired in the next room, or wherever he happens or she happens to 
be…because it's on the surface, and you actually kind of can see it and visualize it -
- not just imagine it being there -- it just -- it's a very, very rewarding, rich 
experience. 
One intraoperative participant observed that the wide array of surgical skill and talent, 
compassionate care, and the intellectual capacity exhibited in the operating room denoted a 
serendipitous type spiritual component for her. 
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 Aside from the operative procedure, spirituality was expressed in a variety of experiences 
by other members of the health care team. One participant described it as a spiritual experience 
when a patient saw himself in the mirror for the first time. In this instance the participant 
defined spirituality as "a desire to maintain his dignity." Many participants also credited the 
donor families when discussing the spirituality of the experience. They expressed awe and 
acknowledged the courage that making such a difficult decision requires, while suffering such 
grief. Few were able to conceptualize what the experience would be like for a family, and 
marveled at the strength they exhibited. 
Esprit de Corps 
 There was a tremendous enthusiasm and appreciation expressed by the participants at the 
opportunity to be involved in such an innovative undertaking. They expressed “honor,” “pride,” 
and “joy” at being included in something that was “a very big deal scientifically and socially.” 
The participants spoke with fondness and reverence for the leadership of the effort, and were 
respectful and cognizant of the strength of the inter-disciplinary teams caring for the patients. 
Additionally, participants believed that the Brigham and Women’s hospital provided an 
environment which exhibited a social, intellectual, and historical architecture supportive of 
innovation “steeped in history.” Together, the subthemes of leadership, teamwork, and 
environment constitute the theme “esprit de corps:” a positive morale and a capacity of the team 
members to exhibit enthusiasm and strong regard for a common goal of altruistic and ethical 
care of the facial transplant patient. Across and within disciplines the thought processes toward 
positive patient outcomes and a profound level of commitment were shared.  
 Leadership.  The first subtheme identified in the theme Esprit de Corps was Leadership. 
The leader of this innovative effort was defined by the participants in terms of a “sincere and 
ethical desire to help the most severely disfigured patients.” One participant described it in this 
way: “when I asked him questions, I could look into his eyes, and I could see the pain that he 
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feels for his patients who need help.  You could see it.  I could feel it.” Without exception, there 
was a belief in the altruistic motivation of the lead surgeon, which instilled trust in the other 
members of the healthcare team, caused them to desire involvement in this innovative 
procedure, and gave meaning and direction to the effort. This meaning and direction allowed the 
care team members to use their energies to develop care protocols specific to their disciplines, 
rather than debate the goals, objectives, and ethics of the innovation. Importantly, several 
participants also articulated the role of the lead surgeon's mentor as an honorable and authentic 
leader which similarly created an enormous confidence in, and vitality to, the undertaking. One 
participant explained the mentor’s role as the one who “had true faith” that “all of this would 
work.” Another explained the inherent confidence he instilled in the health care team in this 
way: “you know that (if) he's behind this, then you have to know that this is good.” 
 Teamwork. The second subtheme within Esprit de Corps was Teamwork. All participants 
were cognizant that a multidisciplinary health care team was involved in facial transplantation 
surgery and patient care. Most were able to articulate the majority of specialties involved and 
respectfully acknowledged their contributions. One participant described the team effort in this way: 
“These are massive undertakings that involve a huge number of people.  It's pretty -- it's a logistical 
circus in the sense -- not in the negative sense.  But there's a lot of moving parts.” Most were able to 
articulate the importance of a team approach to providing optimal care to this patient population. 
Two types of teams emerged.  
 The first type of team was intra-disciplinary. In particular, participants from the plastic 
surgery physician team expressed an exceptional level of collegiality which philosophically and 
logistically supported the undertaking. Though specifically expressed by members of the 
division, importantly, the relationships within the division were observed and revered by other 
members of the health care team as well. This spirit of collegiality contributed to a sense of 
personal well-being and tremendous cohesiveness amongst many of the participants. The 
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significance of the role of mentor/mentee and generational support within the division was 
palpable. 
You'd think, in these type of things, there's a lot of egos that would be clashing, and 
people are kind of muscling in to take different parts of the case.  That actually doesn't 
happen at all.  It's pretty seamless… people are willing to help each other out in a very 
real way here.  And it's more than just lip service.  It's really kind of an esprit de corps 
that characterizes the division.   
  The second type of team that emerged was inter-disciplinary. This type of team was made up 
of multiple individuals with discipline specific skills which were coordinated to achieve a common 
goal. One example cited was the collaboration between the clinical staff of the hospital and the New 
England Organ Bank. One participant noted that other areas of the country have not had this level of 
cooperation from their regional organ bank, making efforts difficult. Another example of a 
constructive inter-disciplinary team was the health care team involved in the care of a donor patient 
and their family in the intensive care unit. The most poignant example of the success of an inter-
disciplinary team however was conveyed by several of the participants. This team consisted of those 
individuals responsible for the intraoperative care of the patients during the facial transplantation 
procedures.  The participants from these teams expressed great reverence for the interdisciplinary 
teamwork that occurred. Many felt that the commitment and level of teamwork was exceptional and 
likely atypical of other clinical situations. One member of the intraoperative team described it this 
way: 
            I mean, I've been involved with other surgical procedures that have not been the 
common, everyday thing that I've helped with over the years here; working with 
different surgical teams. None of those were quite the same as how far out front this was 
of what we've done here.  And I just really love being part of that team. 
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As the participants reflected on their overall experience of participating on highly functional 
teams, they discussed activities that ensued during the preparatory and training phase of the 
procedure, outlined areas for improvement, and made recommendations to enhance the program 
going forward.  
         Training. The participants reported varying levels of preparation in anticipation of the first 
transplant. This created a dual environment of excitement and worry among some disciplines in the 
clinical setting. Some disciplines were critical of themselves; that they had not done enough 
preparatory work. Though many of the skills needed were transferable from other complex 
reconstructive procedures, the participants acknowledged the importance of defining their role in 
what care for facial transplantation patients would be for the future. In spite of now having cared for 
four facial transplant patients however, some disciplines admitted to still not yet formalizing written 
discipline-specific protocols. Additionally, some disciplines struggled during the early phases of the 
innovation with how many practitioners to involve and train in the care of the patients. 
Philosophically, some felt that a few specially trained senior level individuals should care for each of 
the patients. In other areas, an effort was made to train multiple individuals. These philosophical 
differences became difficult in some settings. Some intra-disciplinary groups acknowledged that 
these discussions were likely inherent to innovation, though one group rebuked that the 
revolutionary implications of the procedure gave some the desire to be exclusive.  
         Recommendations.  Many participants described a need for a routine meeting time when the 
entire healthcare team would confer on the facial transplantation patient’s care. Some of the 
participants feared that the organization of such meetings had eroded over the course of time and 
that discipline specific meetings had replaced multidisciplinary meetings. Staff on the post-operative 
unit recommended daily psychiatry and social worker visits to the patients. Others articulated the 
desire to have a representative of psychiatry attend the multidisciplinary meeting to give guidance 
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regarding the patient experience; specifically answering the health care team member’s questions 
about how, when, and if, to engage the patient in conversation about his facial graft.  
 Another area of concern expressed by some disciplines, specifically those who did not 
have a preoperative role in the patient’s care, was the notion that it would be beneficial to meet 
the patients prior to their transplants. This was particularly true of those responsible for 
coordinating discharge planning and social and family interactions. In contrast, others reported 
that not having known the patient preoperatively likely made caring for them postoperatively 
easier because “they become almost a new person.”   
 A major recommendation among the intraoperative staff was the need to limit the number of 
people allowed in the operating room. Despite acknowledging the novel nature of the procedure, the 
institution’s philosophy of education and training, and that efforts had been made to involve the 
security department, there remained considerable concern about infection control and patient privacy 
issues.  
 Among the post-operative staff, it was expressed that a more interconnected approach within 
the nursing units would be beneficial and the formalization of care protocols. The suggestion was 
made for earlier collaboration between perioperative nursing staff and the intensive care unit, and 
then between the intensive care staff and the patient floor nursing staff, thereby promoting a more 
comprehensive care plan for each patient. 
 Environment. The third subtheme that emerged within Esprit de corps was Environment. In 
addition to a strong intellectual environment described earlier in the leadership and teamwork 
sections, the participants described both the historical and ethical environment at the Brigham and 
Women's Hospital as providing the architecture for successful innovation. Though these were more 
intangible elements to the health care team, they were emphasized and recognized as critical 
elements in a similar way. The value of demonstrated success with innovation at the hospital 
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throughout its history, and the belief that the work was being undertaken in an ethical environment, 
was recognized and appreciated by many members of the health care team. 
 Historical Environment. Many participants acknowledged a historical “aura of support” citing 
the Brigham’s work carrying out the first kidney transplant as a principle example.  One participant 
explained “We've been doing kidney transplants at the Brigham, especially before anyone else.  So, 
there's more than 50 years worth of patient experience.” Another explained “it's really good to be at 
an institution where you have both a historical support, and also an immediate support; that everyone 
is prepared to pitch in and help, and offers their expertise.”  
 Likewise, participants were aware that other complex procedures in the field of plastic 
surgery reconstruction had been successfully undertaken at the hospital “Things that seem sort 
of odd or unusual are part of the culture here” one participant described. This gave confidence 
to many members of the healthcare team who described the Brigham as a “natural scientific 
leader” and hence a likely venue for such work. One participant said: 
And from the transplant point of view, I mean, Joseph Murray, who's actually a plastic 
surgeon and -- in the -- you know, with his research and his kidney transplant.  I mean, he 
just set the tenor for the place. And that's kind of been an established fact that the 
Brigham is a transplant institution.  And what followed was all the other types of 
transplants.  And so, it was actually not -- it was certainly understandable that the -- that 
the non-vital organs, the faces and the hands, would also -- you know, maybe not start 
here, but certainly really pick up here.   
 Ethical Environment. No participant expressed concern that the institution’s motivation to 
undertake the effort was fueled by any factor other than a desire to provide ethical and 
compassionate care. Participants expressed very few ethical concerns about the undertaking other 
than those specific to patient selection presented earlier. The participants strongly believed that 
altruism was the foundation of the innovation at the institution. Participants vehemently dismissed 
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ego, fame, or fortune as primary motivating factors. In fact, this core belief comforted some who 
admitted that they were not fully informed about the ethical issues in the literature regarding facial 
transplantation 
 Most participants in this study were aware that the procedure had been regarded as 
ethically controversial when it was in the conceptual phase. Most were also able to affirm that 
they were aware of the individual issues when they were presented to them. None of the 
participants however reported any of the ethical concerns mentioned were troubling enough to 
them to give them pause or tempt them to choose not be involved. Some participants were 
aware of colleagues who had chosen not to participate in the care of this patient population 
based on ethical issues, though importantly this was not wide-spread, nor did they speculate on 
the reasons.   
  In general, the participants could be separated into two groups with regards to knowledge 
about ethical issues: those who had been fully informed and those who had been arbitrarily 
informed. The level to which the participant was informed was generally reflective of their role 
on the healthcare team and the length of time of that involvement. Those who had been 
involved in the planning stages of the procedure, had cared for the patients over a long period of 
time, and those responsible for releasing information to the general public were able to 
articulate a wide range of issues in the literature and fluently offered explanations of how each 
issue had been addressed within the institution. This group of participants was aware of IRB 
restrictions and requirements regarding patient selection and clearance, that the current IRB 
approval had evolved from an earlier version which had narrowed the patient inclusion criteria 
to those who were immunosuppressed, and believed that efforts had been made to protect the 
patient's autonomy regarding decision-making. They were well-informed about a range of 
ethical issues: immunosuppression, the question of an ability to obtain a fully  informed 
consent, potential challenges with identity, the necessity to have an alternative plan should the 
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graft fail, and the economics of the procedure. They were also able to speak to the future 
implications of the procedure for a broader group of patients and hence believed they had an 
ethical responsibility to assure its development. There was a degree of comfort among them this 
group and believed the patient selection process had been fair, patient-centric, and ethical. 
Overall it was clear that this group of participants had spent considerable time reflecting and 
discussing the ethical issues inherent to this surgical innovation. 
 The other group of participants, those who had been arbitrarily informed of the ethical 
issues focused on a few select issues, specifically: patient selection criteria and the finances 
supporting the effort. When questioned, these participants believed that the patient's were well 
informed- to the extent possible- of the postoperative course and lifelong medication regimens. 
They expressed concern and fear however that some of the patients might be unable to adhere to 
the complicated postoperative care routine and that some of the patients appeared to have 
limited social supports in place to assist them. Many expressed dire concern about the financial 
responsibility of such lifelong care. One participant said: 
And then there's a notion of kind of larger societal concerns about allocation of finite 
resources, and whether it makes sense to spend the money that we have -- what little of 
what we have right now on facial transplantations, when that money could be spent to 
take care of 100 diabetes patients, for example. 
  Participants widely acknowledged that the surgical team and the hospital had received 
extensive positive publicity following the procedures however this was not viewed as a 
motivating factor in the effort.  Most speculated that all who were involved in the procedure, as 
well as the hospital’s administration, were likely “quite pleased.” One participant described it 
as:  
        At the same time, I think a lot of good will and a lot of good press was obtained by the 
hospital.  So, it's kind of a win/win situation.  But the most critical thing is, the patient is 
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the one that win/wins.  And as a by-product of that, I think everyone involved with it has 
a positive outcome, including the hospital. 
 There was a great deal of discussion among the participants about the media coverage of 
each of the patient’s hospitalization, and public disclosure of the nature of the patient’s injuries 
which illuminated potential ethical concerns on the part of some of the participants. Some 
denounced the media as intrusive and a violation of the patient's privacy and therefore presented 
ethical concerns. Though the participants understood why the recording of a historical 
procedure might be an important undertaking, many expressed frustration and viewed this 
element as a risk to patient care. This was particularly true of the operating room staff who was 
concerned about asepsis and patient privacy.  
 Media coverage took several forms, and some participants wondered if one particular 
media event that had taken place, and resulted in extensive national coverage, was really in the 
best interest of the patient. Others wondered if the patient really understood the implications of 
involvement or felt coerced to participate, though none indicated that they believed that was the 
case. Several participants wondered if the same type of publicity would have occurred if the 
outcomes had not been positive. Some surmised a delay in the media releases until the patients 
were assuredly more stable, so that the surgeon’s could tell a “confident story,” and wondered if 
this could be interpreted as a maneuver to control facts and therefore a potential ethical 
problem. One participant believed the delay was appropriate:  “there's a positive side to -- you're 
not just showing off.  You're actually telling a very interesting story, with the hope that more 
people may become donors.  And so, it would help other people.”  
 In spite of the perceived media intrusion, there was an aura of respect and appreciation for 
the efforts of the hospital community to respect the patient's privacy immediately prior to and 
after the transplant procedures. Most participants expressed amazement at the ability of the 
hospital community to maintain a level of secrecy about these procedures during the immediate 
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perioperative period. The participants were complementary of the institution as a whole around 
this, though a few caregivers expressed concern that lines of communication were at times too 
constrained and inhibited planning patient care.  
Summary 
 Twenty-six members of the health care team were interviewed to explore their experiences of 
involvement in facial transplantation surgery and related patient care. Two main themes, “individual 
sense of purpose” and “esprit de corps,” emerged from the data.  
  The theme “individual sense of purpose” was comprised of three subthemes: “getting it 
right,” “transforming a life” and “spirituality.” Descriptively, their experiences were defined with a 
seriousness of purpose to “get it right” in order to assure that the patient would have a positive 
“transformation of (his/her) life.” They exhibited vigilance to be attentive and thorough in their care. 
In examining the influence of this innovative event on their lives, they often acknowledged a 
significantly heightened sense of spirituality. Together, these factors yielded a personal and 
professional “individual sense of purpose” for the participants. 
 The theme “esprit de corps” also encompassed three subthemes: “leadership,” “teamwork,” 
and “environment.” Throughout the individual interviews the participants collectively expressed 
intense “honor,” “deep pride,” and “awe” at the opportunity to be involved in this innovative 
undertaking. They also articulated intense trust in the leadership, and acknowledged the institution’s 
motivations as being ethical. They viewed the experience as transformative to the patients, to the 
donor families, and to themselves, which consequently impacted them at an intensely spiritual level. 
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Chapter 5 
Discussion 
Introduction 
        The purpose of this study was to explore the experiences of the health care team involved in 
facial transplantation surgery and related patient care utilizing a qualitative descriptive method. The 
main findings were that the participants found the experience to be personally and professionally 
rewarding on an individual basis and recognized that the commitment and collaboration of the entire 
health care team had been extraordinary. As such, most participants believed that the overall 
experience of this innovative procedure exceeded other novel undertakings with which they had 
been involved in terms of spiritual impact and intrinsic rewards. This was expressed through a 
regard for the quality of the effort’s leadership, through deep reflection on the value of being 
involved in the profound transformation of another human being, and through an awareness of the 
strength of the institution’s intellectual, ethical, and historical environments where the procedures 
occurred.  
        First, these findings will be discussed in relation to the study’s conceptual framework: Moore’s 
“Ethical Criteria for Surgical Innovation” (1970, 1988, 1989, 2000). Importantly, this chapter will 
include a suggested framework modification applicable to innovative efforts that represent major 
paradigmatic shifts in both scientific effort and social philosophy as epitomized by facial 
transplantation. This framework modification will introduce the concept of a “Surgical Innovation 
Cluster.”  Second, the study’s major findings will be compared to prior empirical evidence. Finally, 
the chapter will present implications for practice and health policy, propose areas for future research, 
and summarize the study’s limitations. 
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Conceptual Framework: “Moore’s Criteria for Ethical Acceptability of Surgical Innovation 
        Moore’s “Ethical Criteria for Surgical Innovation” provides four conditions to evaluate when 
determining the ethical acceptability of an innovative procedure or technique (1970, 1988, 1989, 
2000) (Figure 2). The criteria are: the scientific background of the innovation, the skill and 
experience of the team (“field strength”), the ethical climate of the institution, and the extent to 
which public and professional evaluative discussions have occurred (Moore; Wiggins et al., 2004, p. 
7).  
         The Specific Aims of this study reflected these criteria. Specific Aim #1 sought to describe the 
skill-set, attitudes, and experiences of the multi-disciplinary health care team members involved in 
facial transplantation surgery and patient care. Specific Aim #2 sought to describe the ethical impact 
on the multi-disciplinary health care team members involved in facial transplantation surgery and 
patient care. 
         When appraised according to Moore’s framework, the health care team members who 
participated in this study confirmed the ethical acceptability of facial transplantation surgery and 
patient care in their setting. Data analyses validated that the participants believed that the surgical 
team had been congruent with the tenants of the framework: there was an established scientific basis 
for the procedure (“scientific background”), the health care team possessed the intellectual and 
technical skill set required (“field strength”), and the effort was supported by an institutional climate 
which was grounded in beneficence (“ethical climate of the institution”).  
         The major findings of this study are encompassed within two main themes: individual sense of 
purpose and esprit de corps. It is within selected subthemes of each of these that a direct alignment 
with Moore's framework is exemplified. Specifically, the participant’s expression of confidence, and 
their ability to give specific examples of the health care team’s intellectual and technical capacity to 
undertake the innovative procedure (subthemes "getting it right” and “teamwork”), along with their 
strong desire for positive patient outcomes (subtheme “transforming a life”), exemplifies two major 
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concepts depicted within Moore’s framework: “scientific background and field-strength” (1970, 
1988, 1989, 2000). The subtheme “environment” includes data that describes the ethical impact of 
the procedure on the individual health care team members, the motivational climate of the 
undertaking at the institution, and the extent to which the effort was evaluated and critiqued on a 
scientific, ethical, and social basis. These concepts are depicted in Moore’s framework: “ethical 
climate of the institution” and “open display and discussion.” 
Conceptual Framework Modification: “Surgical Innovation Cluster 
        Although Moore's framework provided an appropriate foundation by which to assess the ethical 
acceptability of this innovative surgery, it does not go far enough to reflect all of the elements 
ascertained as essential components to the surgical innovation in this study. These components, 
derived as concepts from the experiences of those involved in facial transplantation surgery and 
related patient care, are suggested as necessary to frame an innovative effort which stretches the 
boundaries of a surgical innovation to extraordinary levels. In these circumstances, the boundaries of 
innovation exceed what is commonly expected in “cutting edge” efforts.  As such, there is a shift in 
the paradigm of what is commonly accepted as surgically possible, often providing revolutionary 
outcomes for science and society. Markedly, these efforts also generate wide-spread human interest, 
and have the potential to create fascination and intrigue through a wide variety of media formats.  
Consequently, those who participate in the innovation’s development and implementation have a 
potential for astonishing personal experiences and outcomes. A brief overview of surgical innovation 
and an introduction to “Cluster Theory” and their applicability in this setting, are presented here.    
       Surgical Innovation. The interest in, and study of, innovation in the science of surgery is not 
new. Nonetheless, the field of surgery presents an interesting dichotomy with regards to its 
evolution.  Surgical expertise is dependent on continuous evolution and refinement of techniques 
and innovative technologies, yet it is steeped in tradition and reverent towards the contributions of 
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those who have gone before. This dichotomy was exemplified as a valued premise within the 
findings of this study. 
        Cluster Theory. The concept of a “cluster” has been described by Michael Porter (2001, 2006, 
2008), Professor at the Institute for Strategy and Competitiveness at Harvard Business School. Porter 
is the foremost authority on clusters as they apply to business strategy and competitive theory 
(Harvard Business School, n.d.). Porter broadly defines a cluster as “a geographically proximate 
group of interconnected companies and associated institutions in a specific field based on 
commonalities and complementarities” (Harvard Business School, n.d.).  A cluster avails “access to 
specialized inputs, services, employees, information, institutions, and public goods (e.g. training 
programs)” resulting in “specialized knowledge creation” with increased efficiency and productivity 
(Porter, 2006). Cluster theory has been applied in relation to global economic development (Ketels, 
2003). Other examples include the automotive industry, the media industry in Hollywood, and the 
fashion and textile industries of Northern Italy (Ketels). 
         The productivity potential of a “cluster” has been otherwise applied. The accomplishments in 
Concord, Massachusetts, during the mid 1800s when Ralph Waldo Emerson brought together a 
group of intellectuals (Henry David Thoreau, Louisa May Alcott, Nathaniel Hawthorne, Henry 
James, Oliver Wendell Holmes, Henry Wadsworth Longfellow, Horace Mann) resulting in our 
country’s great American literary works is a poignant illustration (Cheever, 2006).  
         Innovation Cluster. The concept of “innovation clusters” has been also described by Michael 
Porter. According to Porter (2006), innovation is “stimulated and enabled” by comprehensively 
assembled “clusters” as they encourage a broad interpretation of opportunities, provide multiple 
sources of knowledge, and capitalize on available resources, supplies, and technology within a given 
geographic region. Less broadly, the concept of “innovation clusters” has been pragmatically applied 
in medicine in the settings of the life sciences (Massachusetts Life Sciences Collaborative, 2008), 
biotechnology, pharmacology, and medical device development (Porter, 2001).  Still more situation-
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specific is the concept of a “surgical innovation cluster,” as depicted in Figure 3. Surgical innovation 
clusters have not been previously described in the literature.   
 
 
Figure 3.  Cluster Theory and Innovation Clusters (Porter, 2001)  
 Surgical Innovation Cluster. The synthesis of the findings of this study suggest that a 
comprehensive set of conditions- a “surgical innovation cluster”- enabled the successful 
implementation of facial transplant surgery at Brigham and Women’s Hospital. These circumstances 
include: a valid, evidence-based, scientific background for the procedure and highly-skilled multi-
disciplinary individuals. These individuals formed multiple, highly functioning inter and intra-
disciplinary teams. Importantly, these teams were guided by a shared mental model of transforming 
the quality of life of a human being in an extraordinary way.  Furthermore, there was evidence of a 
comprehensively sound ethical environment during the procedures’ planning and implementation, 
and was led by individuals who were trusted and admired by those involved. Together, these 
conditions were supported by a history of successful institution-based innovative undertakings in the 
field of organ transplantation. These conditions characterize a “surgical innovation cluster.”  
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         The components of a surgical innovation cluster which were not previously described 
within Moore’s ethical criteria for surgical innovation are: the extension of “field strength” to 
include health care teams which represent esprit de corps, the importance of an historical influence 
within the institution’s environment which supports innovation, and the critical role of leadership are 
illustrated in Figure 4.  
 
Figure 4. Surgical Innovation Cluster 
Consequently, a surgical innovation cluster has the potential to transform the life of the 
patient in an extraordinary way, and for the health care team, may result in expressions of personal 
transformation and expressions of spiritual growth. These components will be further defined as they 
are proposed within a “surgical innovation cluster.”  
    Teamwork. The teams involved in an effort encompassed in a “surgical innovation 
cluster” reflect individuals that are not only highly skilled, but are often “best in class.” Moreover, 
the development of highly effective inter-disciplinary and intra-disciplinary teams which possess 
confidence, commitment, and a common morale of beneficence while exhibiting a determination to 
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“do the right thing,” are foundational to the concept. These qualities were evident in the experiences 
of the health care team members participating in this study. 
  Environment. A well-defined intellectual and ethical architecture within an institution is an 
essential component for successful innovative efforts. The health care team members in this study 
however, described an additional environmental domain which influenced the confidence and 
commitment of those involved. This realm consisted of a historically-based precedent specific to 
successful innovation in the field of organ transplantation at their institution, and likely provided 
intangible support for the confidence of the team undertaking the innovative effort. 
Historical influences have been previously suggested when discussing the results of talented 
individuals who have congregated geographically and temporally close and achieved extraordinary 
things. The idea that “genius attracts genius” has been described in reference to the work of the great 
philosophers Plato, Aristotle, Aeschylus, Aristophanes, Euripides and Sophocles (Cheever, 2006). In 
ancient Rome, there was “speculation that geniuses inspired envy, which attracted younger men in 
two ways: they came for inspiration, and they came in the hope of equaling and surpassing those 
who would teach them” (Cheever, p.5). As such, the historical significance of other successful 
innovative efforts in the field of transplantation at Brigham and Women’s Hospital likely had a 
positive effect on those involved in the facial transplantation effort. 
  Leadership. A surgical innovation cluster must be led by an individual(s) that imparts 
integrity, humility, and dedication in the setting of comprehensive risk-benefit analysis, while 
imparting a sense of purpose, meaning, and direction to all involved. These important characteristics 
of leadership have been extensively outlined by Warren Bennis (1985, 1997) and accurately depict 
the views of the participants in this study. These qualities are essential to “translate intention into 
reality and sustain it” (Bennis, 1985, p. 64). Bennis also describes the importance of leadership as it 
applies to the incorporation of the media, “as it is available to those people who oppose a particular 
decision as well as those who support it” (p. 64-65). This is one particularly critical role of the leader 
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in a surgical innovation cluster, as the innovative undertaking approaches extraordinary boundaries 
and elicits significant fascination and public interest. Such was the case with facial transplantation. 
 Spirituality. The findings of this study support the premise that extraordinary innovative 
efforts in surgery may impact the health care team’s personal perception of involvement on a 
spiritual level. It is emphasized here however, that an effort developed and implemented by a 
“surgical innovation cluster” has the potential to exhibit expressions of “awe” by those involved, 
while recognizing that the experience exceeds the spiritual experience of other novel undertakings. 
Summary. The findings of this study support the development of a new conceptual 
framework useful in guiding innovative efforts which represent major paradigmatic shifts in both 
scientific effort and social philosophy. The framework represents a “Surgical Innovation Cluster.” A 
“Surgical Innovation Cluster” consists of the following components: Moore's four criteria for the 
ethical acceptability of an innovation (scientific background, field strength, ethical climate of the 
institution, and public critique of the innovation) undergirded by an esprit de corps that includes 
exceptional teamwork, an environment which is strengthened by a history of successful innovation, 
and guided by exceptional leaders. The innovative effort often results in spiritual reflection by those 
who participate in the undertaking.  
        A “surgical innovation cluster” then, is operationalized as: the leveraging of a 
knowledge base grounded in superior theoretical and clinical expertise, energized by an 
infrastructure rich in extraordinary technical skills and advanced surgical technologies, and fostered 
in a patient-centric, ethically sound environment whose foremost focus and motivation is on positive 
patient outcomes. The outcome measures of the efforts of a “surgical innovation cluster” are a 
transformed quality of life for the patient following a novel surgical intervention, and a profound 
personal- often spiritual- experience for members of the health care team (Figure 5). An innovative 
surgical procedure may be appraised using this framework not only to evaluate its ethical 
comportment, but in terms of its process, implementation, and outcome evaluations for patient and 
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members of the health care team as well. 
 Relationship to Prior Empirical Evidence  
    As reported by Hibbert (1995,) Regehr, Kjerulf, Popova, & Baker (2004) and Wang & Lin 
(2009), the professional caregiver’s perception of involvement in solid organ procurement and 
transplantation procedures has been found to be morally complex and deeply important. Prior to this 
study, the impact of facial transplantation surgery on the healthcare team had not been explored. 
This study confirmed that the health care team’s experience with facial transplant surgery was 
viewed as similarly important, and in some cases, the participants believed that it exceeded the level 
of significance of other organ transplantation procedures. Among the similar findings to Hibbert’s 
study were: an overall positive perception of the experience of involvement in transplantation 
surgery, and an identified need for stress debriefing sessions to express feelings. Unlike Hibbert’s 
study however, in which the participants were specifically involved with the organ donation process 
and the resultant stress around grief in anticipation of death, the participants in this study expressed 
stress in regards to providing clinical care which would maximize positive patient outcomes for the 
transplant recipient. 
Siminoff, Arnold, & Caplan (1995) found a relationship (r=.62; p=.000) between a healthcare 
provider’s attitude and effects on organ donation; specifically in relation to requesting donation. 
Based on these findings, the attitudes of the health care team regarding facial transplant may also 
affect the number of available donors. As many participants in this study reported hesitation in 
agreeing to donate their own or their loved ones face should the circumstance arise, this may 
represent implications for the number of available donors. Additionally, if the healthcare team 
members who have had generally positive experiences with facial transplantation remain hesitant 
about donation, the general public’s hesitation to donate may be of even greater magnitude. 
The first facial transplant surgery occurred in 2005. Studies addressing the attitudes and 
opinions of healthcare team members toward facial transplant surgery and ethical questions have 
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been conducted (Clarke, Simmons, White, Withey, & Butler, 2006; Clarke et al., 2007; Mathes, 
Kumar, & Ploplys, 2009; Prior & Klein, 2011; Vasilic et al., 2008). However, all were done during 
the conceptual phase of facial transplantation surgery and therefore based on speculation, rather than 
experience. This study found that many of these potentially controversial topics were mitigated by 
an overwhelming sense of desperation of the participants to help patients with complex cosmetic, 
functional, and mechanical facial deficits. The participants in this study unanimously believed that 
the risk-benefit ratio of the procedure overwhelming supported its implementation. 
 The findings of this study are in contrast to some early critics of the procedure during the 
conceptual phase who argued that facial transplant surgery was not “life-saving” in the same manner 
as heart, lung or kidney transplants (Morris et al., 2004; Strong, 2010). Many participants in this 
study felt that the “life-giving” nature of this procedure made it an even more important undertaking 
than other organ transplantation efforts they had been involved with, supporting the published views 
of proponents of the procedure (Alexander et al., 2010; Clarke & Butler, 2009; Pomahac, 2011). 
  Several other ethical issues during the conceptual phase of facial transplantation were 
presented which assessed whether the benefits of the procedure outweighed the risks including: the 
risks of lifelong immunosuppressive therapy and potential medical complications (O’Neil, 2009; 
Powell, 2006; Renshaw, 2006; Wu, Xu, Ravindra, & Ildstad, 2009), the ability to obtain a fully 
informed consent and assure patient autonomous decision-making due to the innovative nature of the 
procedure (Reitsma & Moreno, 2006), the financial burden for such procedures is absorbed by the 
health care system (Kalliainen, 2010), and situations whereby the patient might fail to comply with 
necessary treatment to preserve their transplant which would result in a burden to the health care 
system, including subsequent surgical interventions and treatment. The participants in this study 
believed that the risks of long-term immunosuppression following a facial transplant, though 
concerning, were acceptable to them. This was dependent on the patient being fully informed of the 
risks however. The participants in this study believed that the patients they had cared for seemed to 
76 
 
have a thorough understanding of their options, and that each patient appeared to understand the 
risks inherent to the undertaking, to the extent possible given the innovative nature of the procedure. 
 One area illuminated by the current study, which did not receive wide critique during the 
conceptual phase of the procedure was that of patient selection. These concerns were specifically 
related to psychosocial factors including the nature of the injury, past evidence of risky behavior by 
the recipient, and the strength and availability of psychosocial support systems for the post-
transplant phase. These concerns were intertwined with the financial burden of the procedure and the 
risks associated with non-adherence to postoperative medical regimes which are currently absorbed 
by the health care system. 
Implications for Practice 
 As this is the first study which explores the personal attitudes and experiences of the 
healthcare team members involved in facial transplantation it expands a narrow evidence base. 
Importantly, it supports the Institute of Medicine’s recommendation of a focus on inter-professional 
practice and education (Perlman, 2009). 
  The healthcare team members in this study identified areas of practice in need of further 
development. These included learning to become more comfortable with discussions about the 
"new" face with the patient; and in particular, about sensitive topics such as how one might want to 
deal with past photos, a blended hair color, and the patient’s ability to be recognized in public. 
Though multidisciplinary protocols for facial transplantation are now found in the literature and 
provide guidance for program development (Bueno, Diaz-Siso & Pomahac, 2011; Siemionow & 
Gordon, 2010a), there exists a need for discipline-specific protocols to be reported as well. Though 
the discipline of medicine has now reported extensive case reports and other short-term findings 
related to facial transplantation, few other disciplines, including nursing, have done likewise. 
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 The concept of “surgical innovation clusters” has not been previously described. Development 
of the concept may have implications by which to assure successful development and 
implementation of innovative techniques and procedures in a variety of clinical settings.  
Implications for Research 
 Although early empiric data are now available regarding the technical, immunological and 
psychological aspects of facial transplantation, long-term results are as yet unknown. Research must 
now focus on the long-term functional, mechanical, and psychosocial ramifications of the surgery 
and related treatment in order to fully assess risk/benefit ratios. The experience of the patients and 
the quality of life measurements related to the transplant must be longitudinally explored. 
Additionally, the participants in this study voiced concern about the recipient patient’s psychosocial 
characteristics and questioned whether a relationship between the nature of the patient’s original 
injury and long-term outcomes may exist.        
 The impact of facial tissue donation on the donor family on both the short and long term 
grieving processes must be understood. Assessing the type of social supports needed and other 
beneficial interventions to support these family members would be important to explore. Assessing 
this in regards to long-term outcomes may help to assure positive outcomes, including the potential 
for other families to consent to donation in the future. 
  The concept of innovation clusters has not previously applied in the surgical setting and as 
such, the concept has not been empirically tested, developed, or refined. Outcome measures of 
surgical innovation clusters, including productivity, efficiency, and patient and health care team 
member experiences should be further explored. 
Implications for Health Policy 
 Currently, facial transplantation is regarded as an experimental protocol and as such, is 
regulated by an institution's IRB. Because the surgical procedure and perioperative care are complex, 
and postoperatively the patient will require lifelong immunosuppression, financial implications of 
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the procedure are significant. Both private insurance plans and public subsidies will be required to 
address these issues in the future. Additionally, criteria for the distribution and priority of donations 
must be developed.  
Limitations 
  The study's limitations are primarily reflective of the rare and innovative nature of facial 
transplantation. As such, transferability of findings may be limited. Additionally, data collection 
activities were limited to one setting. Significantly, at the time of data collection the participant’s 
exposure had been with generally positive patient outcomes. It is unknown if participant views 
would be different if any patient had had negative results. It is also unknown if those who received 
an invitation to participate but did not respond, or chose not to participate, did so because of negative 
perceptions about the procedure. Therefore the results may reflect only those with positive 
perceptions.  
The notoriety and media interest of the procedure may have influenced participant’s 
responses. Though no indication of such was evident, participant’s responses may have been 
influenced by their employment status and a potential fear of retribution. A potential conflict of 
interest exists for the researcher who was formally an employee of the institution where the data 
collection occurred, a former colleague of some of the participants, and who also participated in the 
intraoperative care a patient involved in facial transplantation. 
Conclusions 
 The attitudes and experiences of the health care team members involved in facial transplant 
surgery and patient care were explored in this study, which utilized a qualitative descriptive method. 
The Specific Aims of the study and the interview questions were guided by “Moore’s Ethical 
Criteria for Surgical Innovation.” Overall, the participants believed that the risk-benefit ratio of 
facial transplantation favored proceeding with the procedure in the clinical scenarios with which 
they had been exposed. The participant’s experience was challenging and rewarding, and they 
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expressed personal fulfillment from the opportunity to be involved in the transformation of another 
human being’s life. Moreover, the entire effort exhibited highly effective team work which displayed 
esprit de corps, was guided by superior leadership, and illuminated the importance of the clinical, 
intellectual, and historical environment of the institution where the procedures took place. These 
components represent a “surgical innovation cluster,” a proposed framework for guiding surgical 
innovative efforts which represent major paradigmatic shifts in both scientific effort and social 
philosophy. 
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Appendix A 
 
Timeline: The development of composite tissue transplantation 
 
Date Event 
348AD Legendary account of the transplantation of leg by Cosmos and Damian 
 
Late 16
th
 century Transplantation of a nose by Gaspare Tagliacozzi 
 
Early 20
th
 century Canine limb transplant by Carrel 
 
Early 20
th
 century Heterotopic allotransplantation of the heads of dogs by Guthrie 
 
1956 First successful human kidney transplant. Donor and recipient were identical twins 
mitigating risk of rejection 
 
1963 First human hand transplant. Experience acute rejection. Removed 3 weeks after 
transplant in Equador 
 
1994 Re-plantation of full-facial tissue (autotransplant) in India 
 
1998 Second-ever human hand transplant performed in France. First to survive more than 
 two years. Eventually rejected and removed because of non-compliance.  
 
1999-2011 62 hand transplants in 46 patients. No mortality reported. Multiple episodes of 
rejection- successfully reversed with medication management 
 
November, 2005 First human facial transplantation 
 
2006-2011 Sixteen  total additional facial transplantation procedures performed worldwide in 
France, China, Spain and the United States. Two of the sixteen patients undergoing 
facial transplants have died 
 
2009 US Department of Defense acknowledges facial transplant as a research priority in 
effort to care for wounded soldiers 
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Appendix B 
Facial transplantation procedures 2005-2011 
 
 
 
Date Patient Location Lead Surgeon Mechanism of Injury 
November, 2005 38 yr. old 
female Amiens, France Lantieri 
 
Dog bite 
 
April, 2006 
 
 
30 yr. old  
male 
Xi’an, China Hui 
 
Bear attack 
Died July, 2008 presumably  
after stopping 
 immunosuppresents 
January, 2007  29 yr. old  
male Creteil, France Lantieri 
 
Neurofibromatosis 
December, 2008 46 yr. old 
 female 
Cleveland, OH, 
USA Siemionow 
 
Gun Shot Wound 
March, 2009 28 yr.old 
male Creteil, France Lantieri 
 
Shooting accident 
 
March, 2009 
 
 
30 yr. old 
 male 
Creteil, France Lantieri 
 
Burn 
Died of a heart attack during 
subsequent surgery for an  
infection 
 
April, 2009 
59 yr. old  
male 
Boston, MA,  
USA Pomahac 
 
Fall/Traumatic injury 
August, 2009 43 yr. old  
 male Valencia, Spain   Cavadas 
 
Radiation for tumor 
Fall, 2009  
Amiens, France  
 
September, 2009 39 yr. old   
male Creteil, France Lantieri 
 
Shooting accident 
January, 2010 34 yr. old.  
male 
Madrid, Spain Gomez Cia Congenital disease 
 ->deformities 
April, 2010 male 
 
Barcelona,  
Spain 
Barret  
Shooting accident 
June, 2010 35 yr. old 
 male 
Creteil, France Lantieri  
Genetic 
March, 2011 25 yr.old  
male 
Boston, MA Pomahac Traumatic Injury/Burn 
April, 2011 30 yr. old  
male 
Boston, MA Pomahac Car Accident 
May, 2011 57 yr. old 
female 
Boston, MA Pomahac Animal Attack 
Jan., 2012 19 yr. old 
male 
Turkey  Ozkan Burn 
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Appendix C 
Participant Demographic Form 
 
1.  Age:____________ 
2.  Gender:__________ 
3. Race:____________ 
4. Ethnicity:_____________ 
5. Religious background:____________ 
6.  Discipline:___________________ 
7. Role:____________________ 
8. Years working in your discipline:______________________ 
 
9. Years of education:__________________________ 
10. Highest academic degree held:________________________ 
11.  Number of face transplant patients cared for____________ 
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Appendix D 
Participant Demographics 
Category Total Participant Response Percent 
Age 
 26-35 
 36-45 
 46-55 
 56-65 
N=26 
   n= 3 
   n= 9 
   n= 7 
   n= 7 
 
11.6% 
34.6% 
26.9% 
26.9% 
Gender 
 Male 
 Female 
N=26 
   n= 7 
   n= 19 
 
27% 
73% 
Race 
 Caucasian 
 Asian 
N= 26 
   n= 25 
   n= 1 
 
96% 
4% 
Role 
 Registered Nurse 
 Physician 
 Clinical Support Services 
1. Occupational Therapist 
2. Speech Therapist 
3. Physical Therapist 
4. Nutritionist 
5. Social Worker 
6. NE Organ Bank 
 
 Patient Care Support Services 
1. Surgical Technologist 
2. Patient Care Assistant 
3. Security 
4. Public Affairs 
5. Administration 
 
N= 9 
N= 5 
N= 7 
   n= 1 
   n= 1 
   n= 1 
   n= 1 
   n= 1 
   n= 2 
 
N=5 
    n= 1 
    n= 1 
    n= 1 
    n= 1 
    n= 1 
 
34.6% 
19.2% 
27% 
 
 
 
 
 
 
 
19.2% 
Years working in discipline 
1. 1-10 years 
2. 11-20 years 
3. 21-30 years 
4. 31-40 years 
N= 26 
    n= 9 
    n= 6 
    n= 6 
    n= 5 
 
34.6% 
23.1% 
23.1% 
19.2% 
Highest academic degree 
 High school diploma 
 Associate’s degree 
 Bachelor’s degree 
 Master’s degree 
 Doctoral degree 
N= 26 
    n= 2 
    n= 1 
    n= 6 
    n= 10 
    n= 7 
 
7.7% 
3.9% 
23% 
38.4% 
27% 
Number of facial transplant patients or 
procedures 
 One 
 Two 
 Three 
 Four 
 
    
   n= 4 
   n= 3 
   n= 5 
   n= 14 
 
 
15.4% 
11.5% 
19.2% 
53.9% 
 
